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Abstract 
Myasthenia Gravis (MG) is a treatable autoimmune disorder that affects the neuromuscular 
junction. MG is characterised by fatigable muscle weakness of voluntary skeletal muscles 
with the most commonly affected muscles being the eye and facial muscles. Patients of 
African genetic ancestry, particularly juveniles, are more likely to develop ocular muscle 
complications of MG compared to their European counterparts. MG ophthalmoplegic 
complications include persistent difficulty with moving the eyes and blepharoptosis, despite 
treatment. Blepharoptosis, or ptosis, describes the condition of a lowered upper eyelid(s), 
beyond its normal anatomic position. Surgical correction of ptosis is often contraindicated in 
MG patients with severe weakness of the muscles involved in eye closure and in patients 
with active disease. In these cases, a non-surgical solution to elevating the ptotic eyelid 
above the visual axis is required. Objective: To design a patient specific, modular and low 
cost ptosis crutch to elevate the eyelid(s) of myasthenia gravis patients. The ptosis crutch 
should be low cost, modular and adjustable in nature. Method: 16 MG patients (42 ± 23 
years) volunteered to participate in the pre-design phase of the project. Initial eye 
measurements of each participant were taken using photographic measurement. A bottom-
up approach was followed for the design of the ptosis crutch. 3D CAD models of the modular 
ptosis crutch were created in SolidWorks, according to the measured dimensions and the 
predefined design parameters. The ptosis crutch was prototyped using 3D printing. Eighty-
seven design failures were observed before the final design was realised. A design feedback 
loop lead to the discovery of a device that satisfied the specified requirements. The final 
ptosis crutch was tested, in the clinical setting, on 12 MG patients (43 ± 24 years). Results: 
The ptosis crutch was designed to fit onto the superior border of the spectacle frame. The 
ptosis crutch is adjustable along the x- axis to cater for the inter-individual variability of globe 
protrusion. The crutch bar is adjusted along the z-axis and elevated the ptotic eyelid by 
1.96mm (±1.11mm). All of the participants indicated that they would be interested in using 
the ptosis crutch on a long-term basis. Conclusion: The immediate feedback on the ptosis 
crutch from the MG patients has shown a positive outcome for the device. Future work will 
include obtaining long term feedback on the ptosis crutch from all of the users as well as 
investigating manufacturing methods using materials with increased durability. 
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1. Introduction 
1.1 Background to the study 
Myasthenia gravis (MG) is a treatable autoimmune disorder that affects the 
neuromuscular junction. MG is characterised by fatigue and generalized weakness of 
voluntary skeletal muscle, with the eye and facial muscles being the most commonly 
affected (Pruitt & Ilsen, 2010; Nemet, et al., 2014). The cause of muscle weakness is 
a defective neuromuscular junction, whereby the receptors responsible for initiating 
muscular contraction are blocked by the autoimmune antibodies (Pruitt & Ilsen, 2010).  
Estimates from North American data indicate that the prevalence of MG is 200 per 
million (Phillips, 2003). The incidence within South Africa population is similar to the 
rest of the world (Mombaur, et al., 2015). While MG affects individuals of all racial 
groups, patients of African genetic ancestry, particularly juveniles, are more likely to 
develop an ocular muscle complication of MG compared to their European 
counterparts (Heckmann, 2012). The most common symptoms of the ophthalmoplegic 
complications of MG are difficulty with moving the eyes and blepharoptosis. 
 
Figure 1. A photograph of a myasthenia gravis patient with ptosis [photograph used with permission 
from the patient]. 
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1.2 Description of the clinical problem 
Blepharoptosis, abbreviated to ptosis, describes the condition of a lowered upper 
eyelid(s), beyond the normal position [Figure 1] (Ahmad, et al., 2011; SooHoo, et al., 
2014; Walsh, et al., 2006). Ptosis may present as a unilateral or bilateral condition. 
Additional aetiologies of ptosis include muscle disorders as well as aging and 
muscular-aponeurotic disorders (SooHoo et al., 2014). Regardless of the type or 
presentation of ptosis, when it obstructs vision, it is disabling. 
Surgical correction of ptosis is often contraindicated in MG patients with severe 
weakness of the muscles involved in eye closure and in patients with active disease. 
In these cases, a non-surgical solution to elevating the ptotic eyelid above the visual 
axis is required [Figure 2] (Moss, 1982).  An external device that mechanically elevates 
the upper eyelid seems to offer an appropriate solution to clearing the visual axis. 
1.3 Significance of the clinical problem 
Ptosis as a symptom of MG, or other muscular disorders, is a debilitating condition 
that can be improved by using an assistive device to elevate the eyelid. A ptosis crutch 
offers such a solution. Although the ptosis crutch itself is not a novel idea, there is no 
record of a commercial ptosis crutch that is developed and available in South Africa. 
Furthermore, no evidence could be found of a modular or adjustable ptosis crutch in 
the global market. The literature suggests that crutches are currently manufactured 
and fitted on a case-by-case basis (Moss, 1982; Lapid, 2000; Kumar, 2010). 
Figure 2. A photograph of the ptotic eyelid manually elevated to clear the visual axis [photograph used 
with the permission from patient]. 
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Unfortunately, custom making crutches require the patient to have access to the 
appropriate facilities as well as the funds to supports this option. These are two 
luxuries that a large proportion of the South African population, as well as other 
developing countries, do not have. 
The ptosis crutches that are available are permanently fixed to the frame or lens of the 
spectacle, thus limiting the use of the crutch to one pair of spectacles [Figure 3].  
MG affects individuals of all racial groups, however, the outcome of therapy of the 
disease differs across races. Patients of African genetic ancestry, particularly 
juveniles, are more likely to develop ocular muscle complications of MG when 
compared to their European counterparts. Despite the presentation of ptosis in MG 
patients, there is no record of a crutch that has specifically been designed for the MG 
population. The association of treatment resistant and ocular muscle complication in 
MG patients of African ancestry emphasizes the need for a South African solution all 
the more. 
1.4 Research approach 
The current research project includes both clinical and design aspects. Each aspect 
was carried out according to the normal practice of their respective fields. The design 
component followed the method of an iterative design approach. The clinical 
component followed the procedures of a quasi-experimental design. A one group pre-
Figure 3. A ptosis crutch permanently attached to the spectacle frame [taken from Walsh, 2006]. 
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test/post-test design was used to determine the effect, if any, that the ptosis crutch 
had on elevating the eyelid. 
1.5 Research hypothesis 
It is hypothesized that a modular and adjustable ptosis crutch will elevate the ptotic 
eyelid to clear the visual axis.  
1.6 Study aim 
The aim of the present study was to design and construct a modular ptosis crutch for 
the South African myasthenia gravis population. The crutch should elevate the upper 
eyelid to clear the visual axis.  
1.7 Objectives of the study  
1. To determine the anthropometric measures that will inform the ptosis crutch 
design. 
2. To design and prototype a modular and adjustable ptosis crutch suitable for 
the MG population. 
3. To verify the efficacy of the ptosis crutch within the clinical setting.  
4. To investigate low cost manufacturing methods for producing the ptosis 
crutch. 
1.8 Key project parameters 
From an innovative/academic perspective, this project allowed for the development of 
a solution to a problem that is much needed in South Africa. From a social aspect, the 
aim of this product is to design a ptosis crutch that meets the needs and expectations 
of the user including the elements of effectivity, practicality, comfort and affordability 
as well as considering the aesthetic appearance of the crutch.  
The clinical parameters were: 
1. To determine the amount of eyelid elevation required to clear the visual axis. 
2. To determine the size of the crutch that is required to provide upper eyelid 
elevation for children, adolescents, and adults.  
3. To determine the effect that ptosis has on performing activities of daily living. 
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The design parameters were: 
1. To determine the methods of tri-axial adjustment.  
2. To investigate an easy method for attachment and detachment of the crutch. 
3. To select materials to prototype and construct the crutch that will not cause 
skin irritation. 
4. To determine the method of manufacturing the crutch. 
5. To investigate a material with the strength to support eyelid elevation but 
allow for some blinking to occur. 
1.9 Scope of the study 
The present study was limited to investigating an appropriate method for elevating the 
upper eyelid of MG patients. This is a proof of concept investigation. The scope of the 
present study did not go beyond describing a working prototype. In the event that the 
long-term feedback from the MG patients was positive, the appropriate methods of 
manufacturing the device for long-term use were to be investigated.  
1.10 Dissertation overview  
This document describes the research, clinical and design methodologies of the study. 
Chapter 2 (Literature Review) provides an overview of the clinical problem as well as 
contextualises the need for the described solution. Chapter 3 (Clinical and Design 
Methodologies) describes the iterative design process as well as the clinical testing of 
the device that were carried out in order to achieve the design objectives. Chapter 4 
(Design Outcome) refers to the final ptosis crutch design as well as the statistical 
analysis of the clinical results. A comparison of the ptosis crutch to existing designs as 
well as highlighting the socio-economic impact of the devices is highlighted in Chapter 
5.  Finally, Chapter 6 discusses the conclusions and limitations of the study, as well 
as suggesting recommendations for future research. 
 
6 
2. Review of Relevant Literature 
This chapter is concerned with uncovering the need for the ptosis crutch. It seeks to 
present information regarding existing ptosis crutch devices as well as expanding on 
the practices that formed the clinical and design methodologies.   
2.1 Myasthenia gravis 
MG is a treatable autoimmune disorder that affects the neuromuscular junction. MG is 
characterised by fatigue and generalized weakness of voluntary skeletal muscle 
(Nemet, et al., 2014; Pruitt & Ilsen, 2010). The most commonly affected muscles 
include those of the eye, neck, limbs as well as the respiratory muscle. The eye 
muscles involved in eyelid elevation and eye movements are among the first areas to 
display muscle weakness. The cause of the muscle weakness is a defective 
neuromuscular junction, whereby the receptors responsible for initiating muscular 
contraction are blocked by the autoimmune antibodies (Pruitt & Ilsen, 2010). 
The estimates from North American data suggests that the prevalence of MG is around 
200 per million (Phillips, 2003). The prevalence within the South Africa population is 
similar to the rest of the world (Mombaur, et al., 2015). While MG affects individuals of 
all racial groups, patients of African genetic ancestry and particularly juveniles of this 
lineage are more likely to develop treatment resistance of their ocular muscle 
complications, compared to their European counterparts (Heckmann et al., 2012). The 
most common ophthalmoplegic complications of MG are difficulty with moving the 
eyes and blepharoptosis. 
2.2 Ptosis 
Blepharoptosis, or ptosis, describes the condition of a drooping upper eyelid(s), 
beyond the normal anatomic position [Figure 4] (Walsh, et al., 2006).The most 
common symptoms of ptosis include; the inability to fully elevate the eyelid, disruption 
to the visual field (especially loss of superior vision) and difficulty completing activities 
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of daily living. Previous studies have found that visual field impairment to be present 
in individuals with a  marginal reflex distance (MRD) of 1.5mm-2mm or less, with more 
severe ptosis resulting in proportionately greater visual impairment (Meyer, et al., 
1989). Non-specific symptoms of ptosis include blurred vision and frontal headaches 
due to fatigue of the forehead muscles in an attempt to lift the upper eyelids. 
2.2.1 Types of ptosis 
Ptosis may present as either an isolated disorder or in conjunction with other ocular 
and systemic disorders (Sakol, et al., 1999). Although ptosis associated with MG is 
the foundation for this research project, it is important to acknowledge the other 
pathologies of ptosis. The cause of congenital and acquired ptosis can be classified 
as either; myogenic, neurogenic, aponeurotic or mechanical (Sowka, et al., 2001; 
Finsterer, 2003; Edmonson & Wulc, 2005).  
Aponeurotic ptosis is the most common cause of acquired ptosis in adults. It involves 
an abnormality (dehiscence, disinsertion or stretching) of the levator aponeurosis from 
its attachment to the tarsus and pre-tarsal orbicularis muscles (Fujiwara, et al., 2001). 
Myogenic ptosis is attributed to several various muscular disorders involving the 
levator palpebrae superioris. Neurogenic ptosis describes ptosis that results from 
disruption to the innervation of the muscles involved in upper eyelid elevation (Sowka 
et al., 2001). Resistance to the action of the levator palpebrae superioris muscle 
results in mechanical ptosis. The most common causes of mechanical ptosis include; 
trauma to the eyelid and surrounding tissues, benign or malignant tumours of the 
eyelid, dermatochalasis and conjunctival scarring (Sudhakar, et al., 2009). 
 
Figure 4. A photograph of a myasthenia gravis patient with bilateral ptosis [photograph used with 
permission from the patient]. 
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Treatment of ptosis is necessary to reduce visual disruptions caused by the ptotic 
eyelid covering the pupil of the eye, as well as to eliminate aesthetic abnormalities 
(Conway, 1973). Ptosis is usually treated by surgically elevating the eyelid to a fixed 
position. There are a number of situations where surgery is unsuccessful or not 
possible due to additional medical concerns (severe weakness of the muscles involved 
in eye closure) a lack of funding and accessibility for the procedure. While there is a 
vast body of research describing the surgical correction of ptosis, there is currently a 
lack of effective and long lasting non-surgical alternatives for alleviating the symptoms 
of ptosis. 
2.2.2 Visual obstruction 
The eyelid is considered to obstruct the visual axis when it is below the superior border 
of the pupil. The severity of obstruction of the visual axis will, therefore, be influenced 
by pupil size (Cohen & Weinberg, 2010).  
Patients with untreated ptosis may need to hold their head in a chin-up position, 
elevate their eyebrows or manually lift their eyelids using their hands in an attempt to 
clear the visual axis [Figure 5] (Finsterer, 2003).  
 
Figure 5. A photograph of a ptosis patient holding their head in an elevated position, to clear the visual 
axis [photograph used with permission from the patient]. 
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2.3 Existing ptosis crutches 
The crutches that have been developed thus far are scarcely available as they are 
produced for patients on a case-by-case basis (Walsh, et al., 2006). Previously 
described ptosis crutches are permanently mounted to the frame or lens of the 
spectacle [Figure 6]. These devices include a straight or convex crutch bar that 
elevates the eyelid. The patient feedback on these devices indicated that the bar 
exerts uncomfortable pressure on the globe and inhibits the blinking mechanism.  
The lundie loop is an alternative device that was initially developed for blepharospasm 
patients but the application of the device was later extended to include ptosis patients. 
The design uses a loop of wire (usually stainless steel) that is the same size as the 
spectacle lens, thus permitting the user to look through the centre of the loop [Figure 
7 &8]. The top of the loop is covered with silicone tubing, which holds the upper eyelid 
in an elevated position (Ramasamy, et al., 2007). Although widely described in the 
literature as an assistive device, the lundie loop has been reported as an ineffective 
device for elevating the eyelid (Ahmad et al., 2011). An additional setback of the lundie 
Figure 6. Images of existing ptosis crutch devices. A] Walsh, 2006. B] Kumar, 2008. C] Muller Optical. 
D] Vision Care. E & F] World Optic. 
A B 
C D 
E F 
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loop design is its inability to be mounted on different types and shapes of spectacle 
frames (Walsh, et al., 2006). 
The ptosis crutch is not a new method of elevating the upper eyelid, however, there 
are only a handful of practitioners that are still manufacturing the devices. The 
practitioners that manufacture ptosis crutches, do so on an individual request basis. 
No record of a standard ptosis crutch as a solution to elevating the upper eyelid could 
be found.  
2.4 Other eyelid devices  
The eyelid weight is a device that performs the opposite function to the ptosis crutch. 
It is designed to fit the shape of the globe and close the eyelid [Figure 9] (Jobe, 2001). 
While the function of the device has little relevance to the current study, the shape and 
size of this device are of interest to the design of the ptosis crutch.  
Figure 8. The lundie loop elevating the ptotic upper eyelids. [Taken from Ahmad, 2013]. 
Figure 7. The lundie loop permanently attached to the spectacle frame [taken from Ramasamy, et al., 
2007]. 
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2.5 Eye measurements 
The size, shape and position of the eye were important aspects to consider in the 
design of the ptosis crutch. Several eye measurements have been documented to 
quantify the position of the upper eyelid as well as the shape and size of the eye globe, 
contour and fissure. Figure 10 provides an illustration of the dimensions of a normal 
eye, in ambient lighting conditions.  
There is no evidence of a consistent method to evaluate and compare pre and post-
ptosis treatment (surgical or device) (Koushan et al., 2008). Nevertheless, there are 
several gross but available methods for assessing upper eyelid position. The most 
widely used methods to determine the position of the upper eyelid include the marginal 
reflex distance and the vertical palpebral fissure (McCulley, et al., 2003; Flynn, et al., 
2011).  
2.5.1 Marginal reflex distance 
The marginal reflex distance (MRD) is a measure of the vertical distance from the 
centre of the pupil to the centre of the upper eyelid margin in primary gaze. Clinically 
ptosis is recognized by an upper marginal reflex distance of less than 2mm or 
asymmetry of more than 2mm between the eyes (Ahmad et al., 2011).  
Figure 9. A photograph of platinum eyelid weight with a radius of curvature of 12.7mm [Taken from 
Silver, 2009]. 
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2.5.2 Vertical palpebral fissure. 
The vertical palpebral fissure (VPF) is the vertical distance between the top of the 
lower eyelid margin and the bottom of the upper eyelid margin.  
Ptosis is described by the extent of which the upper eyelid covers the corneal limbus, 
or the vertical fissure height or the distance from the centre of the pupil to the upper 
eyelid (Small, et al., 1989). 
2.5.3 Horizontal palpebral fissure 
The horizontal palpebral fissure (HPF) is the measured distance between the lower 
margin of the upper eyelid and the upper margin of the lower eyelid (Barretto & 
Mathog, 1999). Normal HPF values are illustrated in Table 1.  
Table 1. Horizontal palpebral fissure [values taken from Barretto & Mathog, 1999]. 
Population Horizontal palpebral fissure (mm) 
Black adult male 32.29 
White adult male 29.51 
Black adult female 31.46 
White adult female 29.40 
 
3.5mm (mid cornea to lid) 
2.5mm (cornea-lid overlap) 
3mm (pupil diameter in 
ambient light) 11mm (vertical 
corneal diameter) 
Figure 10. A model of the human eye in ambient lighting conditions. [Values taken from Small, R. 1989]. 
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2.5.4 Fissure obliquity 
Fissure obliquity, or palpebral slant, describes the relative position of the medial and 
lateral canthi (Hanada, et al., 2001). Fissure obliquity is determined by the angle of 
inclination of an imaginary line connecting the medial and lateral canthi of the same 
eye (Packiriswamy, et al., 2012). The direction of the slant (upward or downward) 
influences the shape of the contour (Beden & Beltram, 2012). It has been suggested 
that ptosis inhibits the ability accurately assess fissure obliquity.  
2.5.5 Eyelid contour 
The upper eyelid contour is described by the curved shape of the lower margin of the 
upper eyelid. The eyelid contour is a complex line that has a dimension along the 
anteroposterior line. The z-axis component arises as a result of the three-dimensional 
nature of the palpebral fissure as well as the posterior position of the lateral relative to 
the medial canthi (Malbouisson, et al., 2000). The palpebral fissure shape is 
dependent on a number of anatomical features including, the contour of the eyelid, the 
location of the eyeball within the orbit as well as the location of the upper and lower 
eyelid creases (Hanada, et al., 2001). 
2.5.6 Corneal diameter 
The horizontal corneal diameter is remarkably consistent between age, sex and racial 
groups (Van den Bosch, et al., 1999; Augusteyn, et al., 2012). Horizontal corneal 
diameter is reported to be around 11mm on average while the vertical corneal  
diameter is 12mm (Mashige, 2013). The intersection of the horizontal and vertical 
cornea measurements is approximated to the centre of the pupil (Small, et al., 1989).  
2.5.7 Globe projection 
Globe projection is a measure from the deepest portion of the lateral orbital rim to the 
apex of the cornea (Barretto & Mathog, 1999). It is widely accepted that globe 
protrusion is determined by the depth of the orbital cavity, the vertical inclination of the 
orbit as well as the thickness and orientation of its upper rim (Wilkinson & Mautner, 
2003).The literature suggests that the Caucasian population have lower values of 
globe projection when compared to a similar Black population (de Juan, et al., 1980).  
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No difference in globe protrusion between sexes has been reported by previous 
studies (Meazzini, et al., 2015). Table 2 shows normative values for globe protrusion 
measurements. 
Table 2. Globe protrusion measurements from the literature. 
Author Normal value of globe projection (mm) 
 Male Female 
 Black Caucasian Black Caucasian 
Dunsky, 1992 18.20 ± 2.97  17.46 ± 2.64  
Migliori, et al., 1984 18.5 16.5 17.8 15.4 
de Juan, et al., 1980 17.4 ± 2.8 15.3 ± 2.2 17.4 ± 2.8 15.3 ± 2.2 
Barretto & Mathog, 1999 18.23 ± 2.26 17.00 ± 2.65 17.27 ± 1.44 15.98 ± 2.22 
 
 
2.6 Methods of eye measurement 
Despite the eyelids being three-dimensional structures, their topographic anatomy has 
only been described in the frontal plane (Van den Bosch et al., 1999; Malbouisson et 
al., 2000). The two measurement methods that have been described by previous 
studies include digital and manual measurement. 
2.6.1 Digital photograph measurement 
The measurement of eyelid position using a millimetre ruler has been described as the 
gold standard for the assessment of ptosis (Khandwala, et al., 2011). However, this 
method of measurement has been challenged by (Coombes, et al., 2007), who found 
a greater level of reproducibility of digital measurement compared to the manual 
handheld ruler measurement of the eyelid position.  
Computerized image processing has been described as a precise non-invasive 
procedure for determining a variety of eye measurements (Cruz et al., 1998). There 
is, however, no specified method of digital image analysis, in that a variety of different 
programs have been used in previous studies.  
 
15 
2.6.2 Manual measurement 
Traditionally the anthropometry of the eye has been measured using manual 
measurement. There are two common methods of manual measurement. The first 
involves manually measuring various eye dimensions using a millimetre ruler. The 
second method involves taking a photograph of the patient with a known scale in the 
image. The photograph is scaled accordingly, printed and the dimensions are 
measured on the photograph using a millimetre ruler.  
2.7 Materials and methods of manufacturing 
This study includes the use of Acrylonitrile Butadiene Styrene (ABS) as the three-
dimensional (3D) printed material as well as a stainless-steel wire coated in polyvinyl 
chloride tubing. A brief description of these materials is discussed below. 
2.7.1 3D printing as a prototyping method 
3D printing is fast becoming a popular term within health care. It provides a 
sophisticated prototyping method that is capable of customization, increases that 
accessibility of devices and is cost effective when compared to other prototyping 
methods (Ventola, 2014). 
Rapid prototyping is advantageous in the design process of user-centred devices as 
it is ultimately the interaction with the user that confirms or rejects the design. 3D 
printing is the gold standard of rapid prototyping as it seamlessly integrates the CAD 
software with the printer software to create a 3D model of the design (Berman, 2012).  
2.7.2 Polyvinyl chloride 
Polyvinyl chloride (PVC) is an inexpensive plastic material that has a wide array of 
domestic and industrial applications. Within the health sector, PVC is the material used 
for manufacturing. PVC tubing has a greater flexibility when compared to silicone and 
polyethylene tubing. Additionally, there are no reports of PVC causing skin irritation. 
The PVC tubing used in the current study is provided by Figure 11. 
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2.7.3 Acrylonitrile butadiene styrene 
Acrylonitrile butadiene styrene (ABS) is a low-cost plastic that has good strength and 
stiffness properties (Plastics International, 2016). ABS has good aesthetic qualities 
that are further improved by applying acetone vapour based smoothing to the printed 
product.  
2.8 Summary 
Ptosis associated with myasthenia gravis is a debilitating condition that may result in 
obstruction to the visual field of the patient. Surgical correction of ptosis is often 
contraindicated in MG patients with severe weakness of the muscles involved in eye 
closure and in patients with active disease. In these cases, a non-surgical solution to 
elevating the ptotic eyelid above the visual axis is required. A ptosis crutch, which is 
attached to the patient’s spectacle frame offers such a solution. The ptosis crutch is 
not a novel device, however, there is no evidence of a modular and adjustable ptosis 
crutch. Furthermore, there is no evidence of a ptosis crutch that specifically considers 
the MG population.     
A modular and adjustable ptosis crutch, using cost-effective materials and 
manufacturing methods could provide a valuable assistive device to the MG 
population. 
Figure 11. An image of the polyvinyl chloride tubing, from an Alaris© Products extension set. The tubing 
was used to coat the galvanized wire crutch bar. 
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3. Methodology 
The present study investigated the design of a modular ptosis crutch as a low-cost 
solution for elevating the upper eyelids of MG patients. The intended function of the 
device is to elevate the upper eyelid above the visual axis [Figure 12]. 
The novelty of this project includes designing a ptosis crutch for young children, 
adolescents and adults that will be comfortable to use on a long-term basis. The design 
considered both individuals who do and do not wear spectacles as well as 
accommodating for both unilateral and bilateral conditions. 
This chapter is subdivided into three sections namely, I] clinical methodology, II] 
design methodology and III] the iterative design process. An overview of the 
methodology is provided by the methodology flowchart in Figure 13.  
Figure 12. A model illustrating the desired outcome of the ptosis crutch. The ptosis crutch was intended 
to elevate the eyelid from the position illustrated by image A to the position illustrated by image B. Image 
B does not represent a normal eyelid position, but rather an eyelid elevated to a position that clears the 
visual axis.  
A B 
1
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Section I: Clinical methodology 
The purpose of the clinical testing was twofold; pre-design testing sought to gain 
information of the amount of eyelid elevation required as well as qualitative information 
on the effect that ptosis has on their lives. The post design testing sought to verify the 
ptosis crutch functionality. This section will outline the clinical methodology that was 
followed in both the pre and post- design procedures. 
3.1 Variables of interest 
3.1.1 Independent variables 
1. The marginal Reflex distance. 
2. The vertical palpebral fissure. 
3. The horizontal palpebral fissure. 
3.1.2 Dependent variables 
1. The upper eyelid elevation required to clear the visual axis.  
2. The horizontal length of the ptosis crutch. 
3. The obliquity of the ptosis crutch. 
3.1.3 Assumptions 
1. The shape of the globe is consistent across all individuals. 
2. Inter-individual variability of globe projection beyond the lateral canthi exists.  
3. There is no inter-individual variability of the dimensions of a healthy cornea. 
4. The pupil diameter varies according to different lighting conditions as well as 
automatic nervous system activity. 
3.1.4 Controlled criteria 
1. The gaze of the participants was in primary position. 
2. The spectacle frame used for testing.  
3. The camera type as well as the setup and position. 
4. The lighting conditions of the room where the crutch was tested.  
 
 
 
20 
3.2 Research hypotheses 
The null hypothesis (H0) states that a modular and adjustable ptosis crutch will elevate 
the upper eyelid above the current position. 
The alternative hypothesis (HA) states that a modular and adjustable ptosis crutch will 
not elevate the eyelid above the current position.  
3.3 Experimental procedure 
3.3.1 Participant recruitment 
The participant population differed between the pre-design and post-design testing. 
Three patients from the pre-design sample group were unable to participate in the 
post-design testing due to unforeseen circumstances. Three additional patients were 
recruited for the post-design testing. The specific details of each sample group are 
displayed in Table 3. All of the participants included in the current study met the 
inclusion criteria for the study. Prior to testing the participants gave informed consent, 
in the case of minor’s consent was provided by the guardian [HREC REF: 240/2015]. 
Both male and female participants were included in this study as ptosis, associated 
with MG, is not isolated to a specific sex. 
Table 3. Participant information for the pre-design and post-design clinical testing. 
Pre-design Testing Participant Information 
Number of participants 
Total: 16 
Male: 6 
Female: 10 
Age 42 ± 23 years 
Post-design Testing 
 
Number of participants 
12 
Male: 3 
Female: 9 
Age 43 ± 24 years 
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3.3.2 Experimental setup 
The clinical testing involved capturing photographs of the participant’s eyes in primary 
position. The participants were photographed using three Canon EOS 1000D cameras 
with a 18-55mm variable lens. The cameras were secured onto a frame. Each camera 
was connected to a Canon ACK-E5 AC adapter kit, to ensuring that the cameras were 
continuously online. The camera lenses were clamped in position to ensure that the 
focus and focal length were fixed. A trigger switch, mounted to the camera frame 
ensured that all three cameras were fired simultaneously. The images had a resolution 
of 3888 x 2592 pixels. The cameras were set to a high shutter speed (1/60) and an 
aperture of f/5.6. 
3.3.3 Experimentation  
Clinical testing was carried on two separate occasions, namely pre-design testing as 
well as post-testing of the ptosis crutch. The specific procedures carried out during 
each testing session are outlined below.  
Photographs were captured of the participants seated in a marked frame. The purpose 
of using the measurement frame was to provide a fixed frame of reference to 
standardize the measurements. 
3.3.3.1 Pre-design clinical testing 
The initial testing session involved measurement of the natural eyelid position in 
primary gaze, to determine the amount of eyelid elevation that was required. The 
position of the eyelid was measured using the measures of VPF as well as the MRD. 
The additional eye measurements that were recorded and the reason for noting these 
measurements is described in Table 4. Three photographs of each participant were 
taken, the best quality photograph was used for analysis, and the remaining 
photographs were discarded. The participants were required to fixate their gaze on the 
lens of the centre camera, thus standardizing the direction of gaze to primary gaze. 
The position of eye gaze was standardized to primary position to reduce the direction 
of gaze altering the position of the upper eyelid (Coombes et al., 2007).  
Each participant was issued with a qualitative questionnaire to determine the impact 
that ptosis has on their visual field, activities of daily living and quality of life [Appendix 
1.2]. The questionnaire focused on activities and symptoms that might be adversely 
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affected by ptosis. The design of the questionnaire was based on the National Eye 
Institute Visual Function Questionnaire (NEI-VFQ-25) (Mangione, et al., 2001) and the 
10-item Neuro-Ophthalmic Supplement to the NEI-VFQ-25 surveys. An item was not 
required to be answered if the patients did not perform the activity. 
Table 4. The anthropometric measures that were recorded for each participant. 
Measurement Description of measurement Reason for observation 
Vertical palpebral fissure 
The distance from the bottom 
of the upper eyelid margin to 
the top of the bottom eyelid 
margin 
Upper eyelid position 
Marginal reflex distance 
The vertical measurement 
between the centre of the pupil 
and the upper eyelid margin 
Upper eyelid position 
Horizontal palpebral fissure 
The distance from the lateral 
to the medial border of the eye 
aperture 
Length of the crutch. 
Vertical corneal diameter 
A vertical line measuring the 
limbus to limbus distance 
The centre of the cornea is 
approximated to the centre of 
the pupil. The measurement 
informed the elevation 
required to clear the visual 
axis 
 
 
3.3.3.4 Post-design clinical testing 
The post design testing involved the functional assessment of the ptosis crutch. The 
clinical testing of the ptosis crutch involved digital photograph analysis of the 
participant’s ptotic eye under two conditions, specifically with no crutch and when 
wearing the ptosis crutch. The ptosis crutch was fitted to a standard spectacle frame 
that was used during all of the testing sessions. The reason for using a standard frame 
was to reduce any confounding influence that the spectacle frame may have on 
measurements. The experimental setup and procedures for capturing the photographs 
were consistent with that carried out in the pre-design testing.  
Following the photographic assessment, each participant was required to complete a 
questionnaire [Appendix 1.3]. The questionnaire was intended to gain qualitative 
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feedback on the functionality and user experience of the ptosis crutch. The questions 
related to the visual ability of the patient while wearing the crutch as well as the ease 
of use and aesthetic appearance of the crutch.  
Following the clinical testing, each participant was issued with a crutch/ pair of 
crutches that was fitted to their spectacle frame. In the circumstance that the 
participant did not wear spectacles, the participant was given a pair of spectacles with 
a clear lens, to which the crutch was fitted. Following a minimum of a one-month 
period, the participants were contacted to find learn whether they were using the 
crutch. The reasons for disuse were noted. Patients that were using the crutch were 
required to answer questions relating to the user experience of the crutch. 
3.4 Photograph analysis 
3.4.1 Digital analysis 
Digital image analysis was used to measure the position of the eyelid(s) with and 
without the aid of the ptosis crutch. All photographs and clinical measurements were 
taken by the author. 
The digital photographs were imported into Adobe Photoshop 2015 for processing. 
Adobe Photoshop has been reported as an effective tool for measuring various 
dimensions of the eye (Choi & Eo, 2014). The participant photographs were scaled 
according to the pixel/millimetre ratio [Equation 1]. The pixel/ millimetre ratio was 
established by measuring the number of pixels per white sphere on the calibration 
frame (5.5mm). After the photographs had been correctly scaled, the eye 
measurements were determined using the software’s millimetre ruler tool [Figure 14]. 
All measurements were recorded to the nearest 0.1mm. MRD, the vertical and 
horizontal palpebral fissures and the corneal diameter measurements, were recorded 
for both eyes of each of the participants. The cameras were recalibrated before each 
testing session to ensure accurate measurements were recorded.  
𝑝𝑥 𝑚𝑚 = 𝑝𝑥(5.5𝑚𝑚)  
Equation 1. Determining the pixels per millimetre ratio, of the patient photographs, where 𝑝𝑥= pixels. 
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3.4.2. Manual analysis 
Scaled images (1:1) of the same patient photographs that were used for digital 
analysis were printed for manual measurement. White spheres, on the calibration 
frame, with a 5.5mm diameter were used as the reference measurement for scaling 
the images. 
The scaling of the images was cross-checked with a 14mm ellipse that was placed on 
the participant’s forehead [Figure 15]. The photographs of each participant were 
printed using an HP DeskJet Ink Advantage 3525 printer. The vertical and horizontal 
palpebral fissure, fissure obliquity and the distance between the medial and lateral 
canthi were measured using a standard ruler. The manual measurements were 
performed by the same individual. The measurements were recorded to the nearest 
0.1mm. 
The reason for performing both manual and digital measurement was to determine 
whether any difference existed between these methods of measurement. It has 
previously been suggested that digital measurements exhibit greater inter-observer 
variability when compared to measurements obtained by a handheld ruler (Coombes 
Figure 15. A photograph of the manual measurements performed using a millimetre ruler. 
1 2 
3 
4 
1: 1.15cm 
2: 0.89cm 
3: 0.58cm 
4: 0.50cm 
Figure 14. A photograph of the digital measurements. A] Illustrates the MRD, VPF and HPF 
measurements. B] The measurements generated using the Photoshop ruler tool. 
VPF 
MRD 
HPF 
A 
B 
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et al., 2007). Should no difference of the values obtained in the manual and digital 
measurement in this study, only the digital analysis will be used in the post- design 
clinical testing.  
3.5 Determining the amount of eyelid elevation required  
The MRD was used to determine the amount of eyelid elevation that would be required 
to clear the visual axis. Both the MRD and the VPF measurements are reported as 
measurements indicating the position of the upper eyelid (Flynn et al., 2011). Although 
both measurements were recorded in this study, the MRD measurement was used for 
determining the amount of eyelid elevation that was required. It was decided the MRD 
would be a more appropriate measure was as it acknowledges the position of the 
eyelid in relation to the visual axis, while the vertical palpebral fissure provides a 
measurement of the fissure aperture.  
The visual axis was defined as the border of the pupil. It is appropriate at this point to 
acknowledge that the pupil diameter is variable in nature and adjusts according to the 
amount of available light as well as automatic nervous system activity. The pupil 
diameter is well researched and has been reported as having a range between 2 – 8 
mm (Walker, et al., 1990; Watson & Yellott, 2012). Previous studies indicate the 
diameter of the pupil in ambient light to be 3 – 4mm (Small et al., 1989).The functional 
requirement of the ptosis crutch is to elevate the ptotic eyelid above the superior 
pupillary border, thus clearing the visual axis.  
The ptosis crutch was designed to elevate the eyelid, above the superior border of the 
pupil, in ambient lighting conditions, however, the adjustable component along the z-
axis allowed the eyelid to be elevated, to clear the visual field, in all lighting conditions. 
The amount of eyelid elevation required to clear the visual axis in ambient light was 
calculated using Equation 2. In the current study, the superior visual axis is 
synonymous with the superior pupil border. The eyelid must be positioned above the 
superior border of the pupil. 
𝑥 = (
𝑐
2
+ 1.5) − 𝑒 
Equation 2. Determining the vertical elevation of the eyelid in ambient lighting conditions. Where 𝑥 
refers to the amount of elevation required to clear the visual axis; 𝑐 refers to the vertical corneal 
diameter; 𝑒 refers to the current position of the eyelid measured from the centre of the limbus border. 
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3.5.1 Assumptions 
The following assumptions were made when determining the amount of elevation 
required to clear the visual axis.  
1. The centre of the limbus can be approximated to the centre of the pupil (Small 
et al., 1989).  
2. The centre of the pupil is located at the height of ½ the vertical diameter of 
the cornea. 
3. The pupil diameter ranges between 2 – 8mm (Watson & Yellott, 2012). 
4. The diameter of the pupil in ambient light is 3mm (Small, et al., 1989). 
3.6 The usability of the ptosis crutch 
The ISO 13407: 1999 Human-centred design processes for interactive systems 
defines usability as, ‘the extent to which a product can be used by specified users to 
achieve specified goals with effectiveness, efficiency and satisfaction in a specified 
context of user’. In the context of this study effectiveness, efficiency and satisfaction 
were defined with the following criteria 1] Effectiveness referred to the efficacy of the 
ptosis crutch to satisfy the design requirements. 2] Efficiency focussed on the 
minimum and effective use of resources, i.e. a low-cost device. 3] Satisfaction referred 
to the user’s perceived satisfaction of the ptosis crutch.  
The usability of the ptosis crutch was assessed after 8 participants had used the device 
for a minimum of one month. The reason for omitting 3 participants from the usability 
testing was due to the participants not having used the device for a sufficient period of 
time before. The purpose of the usability questionnaire was to determine the initial 
user compliance as well as the usability of the device. The simplest method of 
determining the user compliance of the device is to ask the user the question, “Are 
you using the device?” In the circumstance that the participant was not using the 
device, the reasons for non-use were explored.  
3.7 Statistical Analysis 
3.7.1 Pre-design clinical testing 
A two-tailed t-test (p<0.05) was performed on the manual and digital measurements 
to determine whether there was a difference in the values obtained. Descriptive 
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statistics were used to describe the recorded eye measurements. The results from the 
questionnaire were tabulated and analysed using nonparametric sign-ranked tests. 
3.7.2 Post-design clinical testing 
The data collected in the post-design clinical testing were analysed in STATISTICA, 
where a one-way factor analysis of variance (ANOVA) test (p<0.05) was conducted to 
identify significant differences in eyelid elevation for the two conditions. The results 
from the questionnaire were tabulated and analysed using descriptive statistics and 
using nonparametric sign-ranked tests. 
3.8 Ethical Considerations 
3.8.1 Informed consent  
Prior to testing, the participants were informed about the background and aims of the 
study, as well as the procedures that were involved during the testing session. This 
information was provided in writing as well as verbally upon arrival at the testing 
session. The participants signed a consent form agreeing to voluntarily participating in 
the study as well as acknowledging the risks and benefits to the participants during 
the testing procedure [Appendix 1.1]. Prior to the initiation of the study ethics approval 
(HREC REF: 240/2015) was granted by the University of Cape Town Faculty of Health 
Sciences Human Research Ethics Committee [Appendix 4]. 
3.8.2 Privacy and anonymity of results 
All of the participants were identified using a code, rather than by their names, in order 
to ensure that all of the data remained confidential. The participant’s data was stored 
until statistical analysis was complete. 
Section II: Design Methodology 
3.9 Design Specifications 
The requirements for each of the functional components of the ptosis crutch were 
specified to ensure that the final product met the user’s needs. The design 
specifications were informed by the patient’s needs, clinician’s advice and the design 
considerations of material selection, ergonomic considerations and failure analysis. 
The balance between the clinician, designer and user requirements was of utmost 
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importance in ensuring a successful product. A detailed list of the design specifications 
can be found in Appendix 2. The order of importance of each of the requirements was 
determined through a literature search, patient input as well as analysis of existing 
ptosis crutch devices.  From the critical analysis of the requirements, it was established 
that the elevation of the eyelid above the visual axis was the most important 
consideration. Adjustability along the x and y-axes, modularity, comfort and aesthetic 
appearance were other important considerations.   
The ptosis crutch was broken down into modular components. Each of the 
components carried out a specific function, which together would ensure optimal 
functionality of the ptosis crutch. The components were divided according to the 
following functions; elevate eyelid (movement along the z-axis), adjust for globe 
projection (movement along the y-axis), adjust the horizontal position of the eye 
(movement along the x-axis) and allow for blinking to occur [Figure 16]. In addition to 
these requirements the ptosis crutch needed to satisfy the usability requirements of 
effectiveness, efficiency and user satisfaction [see section 3].  
The data from the pre-design clinical testing as well as the clinician and designer 
requirements were the primary input for the design specifications outlined below:  
Ptosis Crutch 
Elevate eyelid to 
clear visual axis 
Adjust for globe 
projection 
Adjust for the horizontal 
positon of the eye 
Attach to 
spectacles 
Allow for blinking 
Figure 16. A schematic representation of the design functions of the ptosis crutch components. 
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Function 
1. The primary function of the ptosis crutch is to elevate the upper eyelid to 
clear the visual axis. 
2. The device must be capable of accommodating for different degrees of 
ptosis. Thus, the device must be adjustable along the z-axis. 
3. The device must accommodate for the inter-individual variability of globe 
projection. Thus, the ptosis crutch must be adjustable along the y-axis. 
4. The device must cater for differences in the horizontal position of the eye. 
5. The device should allow for some blinking effort to occur.  
Ergonomics 
1. There should be god skin-crutch coupling. 
2. The device should be comfortable. 
3. The ptosis crutch must be easily attached to the spectacles by the user. 
4. The device should be easily and intuitively adjusted by the user.  
5. The device should be efficient in that it should not be resource intensive. 
Safety 
1. The device should not subject the user to any danger. 
2. The device should not provide the opportunity for misuse. 
3. The device should be consistent with the user’s intuition on how the device 
should function. 
3.11 Ptosis crutch design 
The ptosis crutch design process was informed by the patient, clinicians and designer. 
The initial measurements recorded in the pre-design clinical testing as well as the 
HPF, crutch depth and fissure obliquity values, obtained from previous studies, 
informed the size and elevation specifications of the crutch. The measurements are 
displayed in Table 5. It is important to note that ptosis associated with MG varies 
throughout the course of the disease. The inclusion of an adjustable component along 
the z-axis was thus essential as the user needs to adjust the height of the eyelid 
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according to the severity of ptosis. Figure 17 illustrates a step-by-step walk through of 
the ptosis crutch design. 
Table 5. The measurements that were used to inform the ptosis crutch design specifications. 
Measurement Value Source 
Marginal Reflex Distance -1.4mm Clinical testing 
Vertical palpebral fissure 4.2mm Clinical testing 
Measured horizontal palpebral 
fissure 
22.83 Clinical testing 
Desired horizontal palpebral 
fissure 
30mm Barretto & Mathog, 1999 
Fissure obliquity ± 2º Van den Bosch,W.A. 1999 
Depth of the curve 8.5mm Young, A. 2012 
The ptosis crutch followed an iterative design process. SolidWorks 2015 was used to 
create the computer assisted design (CAD) models of the modular crutch components. 
Eighty-seven design iterations resulted in a final design that satisfied the specified 
device requirements. It was ultimately the iterative design process that lead to the 
discovery of a device that satisfied the requirements. The crutch design evolved with 
a clear selection mechanism whereby the crutch needed to satisfy all of the specified 
criteria before it was considered to be successful. In the circumstance that the crutch 
failed to meet the requirements, the reason for failure was noted and the necessary 
iterations were made. Every failure of the design resulted in an improved iteration to 
the successive ptosis crutch. 
The specifications of the final ptosis crutch components are described in the 
subsections below. The engineering drawings for the component can be found in 
Appendix 3. 
3
1
 
P
a
ti
e
n
t 
p
h
o
to
g
ra
p
h
 
(p
ri
m
a
ry
 g
a
z
e
) 
E
y
e
 m
e
a
s
u
re
m
e
n
ts
 
H
o
ri
z
o
n
ta
l 
p
a
lp
e
b
ra
l 
fi
s
s
u
re
 
V
e
rt
ic
a
l 
p
a
lp
e
b
ra
l 
fi
s
s
u
re
 
M
a
rg
in
a
l 
re
fl
e
x
 
d
is
ta
n
c
e
 
D
e
s
ig
n
 
C
ru
tc
h
 b
a
r 
C
o
n
tr
o
l 
A
tt
a
c
h
m
e
n
t 
M
e
a
s
u
re
 s
p
e
c
ta
c
le
 
fr
a
m
e
 d
im
e
n
s
io
n
s
 
A
d
ju
s
t 
fo
r 
g
lo
b
e
 
p
ro
je
c
ti
o
n
 
S
n
ip
 a
n
d
 s
e
c
u
re
 
c
o
n
tr
o
l 
to
 a
tt
a
c
h
m
e
n
t 
F
it
 s
p
e
c
ta
c
le
s
 t
o
 
n
a
s
a
l 
b
ri
d
g
e
 
N
o
 
Y
e
s
 
F
it
 t
o
 s
p
e
c
ta
c
le
s
 
F
ig
u
re
 1
7
. 
T
h
e
 d
e
s
ig
n
 p
ro
c
e
s
s
 o
f 
th
e
 p
to
s
is
 c
ru
tc
h
. 
 
32 
3.11.1 The crutch bar 
The crutch bar is the component responsible for elevating the eyelid to clear the visual 
axis. The crutch bar mechanically elevates the upper eyelid when the user manually  
pulls the control in a vertical direction [Figure 18]. While the amount of required eyelid 
elevation was determined during the clinical testing, the shape of the crutch was 
determined using a combination of the anthropometric measures and dimensions of 
existing devices [see section 2.3.2]. The method for calculating the shape of the crutch 
is outlined in the subsections below. 
3.11.1.1 The length of the crutch bar 
The length of the crutch bar was determined by the measurement of the desired fissure 
width [see section 2.4.3]. The optimal HPF, of 30mm, was used to inform the design 
as the ptosis crutch intended to increase the width of the palpebral fissure by elevating 
the eyelid (Krishnakumar, 2013). The crutch bar makes full contact with 2/3 of the 
eyelid and tapers off on the outer edges of the fissure [Figure 19]. The length of the 
crutch determined the depth of the crutch bar.  
3.11.1.2 The depth of the crutch bar 
The ptosis crutch bar is designed to mirror the shape of the eye globe. The depth of 
the concave curve was determined according to the shape of an existing assistive 
device, namely an eyelid weight [see section 2.3.2]. The eyelid weight is a device that 
Figure 18. The ptosis crutch bar. The concave bar is moulded to the shape of the eye globe. The 
congruency between the upper eyelid and the crutch bar, allowed the crutch bar to make full contact 
with the eyelid. The vertical lever allows for the amount of elevation. 
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serves the opposite purpose to the ptosis crutch. It is placed on the upper eyelid and 
forces the eyelid to close. The design of the eyelid weight encompasses a 12.7mm 
radius of curvature that conforms to the curvature of the eye globe (Blackmore & Jobe, 
1996; Young & Blackmore, 2012). The concave curve of the ptosis crutch was 
designed to have a 12.7mm radius of curvature, the length of the curve was 24mm, 
determined by the horizontal measurement of the eye globe [see section 2.4.8]. The 
height of the curve was calculated as 4.87mm, using Equation 3.  
ℎ = 𝑟 − √𝑟2 − 𝑙2 
Equation 3. The calculation that was used to determine the height of the curved crutch bar., where h= 
the sagitta; r= the radius; l= ½ the width (w).  The height of the curve was calculated as 4.87mm, where 
r- 12.7 and l=24mm. 
The reason for using a 24mm length was twofold. Firstly, it would cater for the 
palpebral fissure of all individuals (i.e. it would not extend beyond the canthi). 
Secondly, it was chosen to be longer than the length of the eyelid weight in order to 
distribute the force of the ptosis crutch over the globe. Excessive pressure on the globe 
may limit the blinking ability and/or cause double vision. The concave crutch bar was 
fitted to a CAD model of an emmetropic eye in SolidWorks [Figure 19], to assess the 
congruency of the crutch and globe curvatures.  
 
A B 
Figure 19. A model of the ptosis crutch bar fitted to the contour of the globe. A] Front view, B] Top view. 
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3.11.2.3 The slant of the crutch bar 
The direction and degree of the palpebral slant differ between individuals (Odunze, et 
al., 2008). The ptosis was designed for a palpebral slant of ± 1.5mm. The directions 
and magnitude of the crutch slant are illustrated in Figure 20. 
3.11.1.4 Additional considerations 
An important consideration was to ensure that the crutch did not exert excessive 
pressure on the globe while elevating the eyelid. This was achieved by having 
maximum contact between the eyelid and the crutch, thus distributing the force over a 
greater area. The device described herein used a concave crutch bar that mirrored the 
shape of the globe [Figure 19]. 
The eyelid contour is a complex line that includes a y-axis component [see section 
2.4.5 for details]. Figure 21 illustrates the 1mm offset of the ptosis crutch along the y-
axis, to ensure that the crutch bar made full contact with the eyelid surface. 
A B 
Figure 20. A model of the crutch bar illustrating the different bars used for upward and downward 
palpebral slants. A] The crutch bar for a downward slanting fissure (right eye). B] The crutch bar for an 
upward slanting fissure (right eye).  
Medial canthus 
Lateral canthus 
Figure 21. A model of the ptosis crutch bar indicating the 1mm between the medial and lateral canthi.  
 
35 
3.11.2 Attachment to spectacle frame 
The attachment component, as the name suggests, is the component responsible for 
attaching the device to the spectacle frame [Figure 22]. This component enabled the 
user to independently attach and detach the device to their spectacle frame. The 
distance between the eyes differs between individuals. The crutch would, therefore, 
need to be adjustable along the x-axis to allow the device to accommodate for the 
inter-individual variability of horizontal eye position. The device adjusts for the 
horizontal position of the eye by clipping the crutch onto the superior spectacle border 
at a position where the medial and lateral canthi are aligned with the outer edges of 
the crutch bar. 
The ptosis crutch attachment is 18mm in length.The height and width of the 
component vary according to the size of the spectacles frame. The attachment is 
secured to the spectacle border through the use of a clip mechanism. The angle of 
deformation is 67 degrees. This allows for sufficient flexibility in the clip while 
maintaining enough rigidity to hold the attachment in a secure position on the 
spectacle frame. The attachment is the only component of the device that is 
customized according to patient specific dimensions. The CAD model can be modified 
in SolidWorks to adjust the height and depth of the spectacle frame. 
Figure 22. The attachment component that connects the ptosis crutch to the superior border of the 
spectacle frame. The attachment is a standard length; the height and width of the clip are adjusted 
according to the dimensions of the spectacle frame. 
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3.11.3 Globe projection component 
The two primary functions of this component were 1] to act as a connection between 
the crutch bar and the attachment component and 2] to allow the device to be adjusted 
along the y-axis, thus accommodating for the inter-individual variability of globe 
projection. The user is able to adjust the position of the crutch bar along the y-axis to 
the position where the crutch bar makes full contact with the eyelid. The control, 
displayed in Figure 23, fits into a rectangular slot (1.25mm x 5.5mm) in the centre of 
the attachment component [Appendix 3]. 
3.12 Prototyping 
The ptosis crutch was prototyped using a combination of 3D printing and manual 
manufacturing. The ptosis crutch was prototyped and tested from the first generation. 
It was the rapid production and interaction with the world that lead to the development 
of the final product. The components of the crutch were 3D printed using several 
different materials before failure testing of each material was performed. The failure 
testing involved testing the durability of the device when being attached/ detached to 
the spectacles as well as when operating the adjustable components. The materials 
that were tested are listed with their corresponding outcome in Table 6. 
3.13 Failure Modes and Effect Analysis 
Following the clinical validation of the ptosis crutch, a Failure Modes and Effect 
Analysis (FMEA) was performed. FMEA is a tool that uses a bottom-up approach to 
Figure 23. The globe projection control. The component is responsible for connecting the crutch bar to 
the attachment component.  
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analyse a system or device. A design FMEA was performed to determine any possible 
failures of the device that may occur in the prototyping process as well as during the 
use of the ptosis crutch. 
Table 6. Thermoplastics that were tested for 3D printing the modular components of the ptosis crutch 
Material Outcome 
ABS 
Attachment – successful 
Crutch bar housing - successful 
Control – successful 
Ultrat 
Attachment - failed, did not provide sufficient flexibility for the clip mechanism 
Crutch bar housing - successful 
Control – successful 
Polyethylene glycol 
(PEG) 
Attachment – failed, the clip was brittle and broke when attached to the 
spectacles. 
Crutch bar housing - successful 
Control – successful 
Glass 
Attachment – failed, the clip was brittle and broke when attached to the 
spectacles. 
Crutch bar housing – successful, however, smoothing the surface was 
difficult. 
Control – successful, successful, however, smoothing the surface was 
difficult. 
  
SECTION III: Iterative design process 
The design of the ptosis crutch followed an iterative process. 87 design iterations lead 
to a ptosis crutch that satisfied the specific requirements of the device. The crutch 
design evolved with a clear selection mechanism. The crutch needed to satisfy all of 
the specified criteria. In the circumstance that the crutch failed to meet the 
requirements, the reason for failure was noted and the necessary iterations were 
made. Every failure of the design resulted in an improved iteration to the successive 
ptosis crutch. 
The major iterations of each component are outlined below. For a comprehensive 
breakdown of the design process and a full list of the iterations involved, refer to 
Appendix 2.  
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3.14 Crutch bar iterations 
The crutch bar underwent a number of iterations during the course of the study. 
Following the determination of the shape of the crutch bar, the method of elevating the 
eyelid was determined. 
Concept 1: The crutch bar was attached to the housing on the spectacle temple. The 
bar was prototyped using ABS.   
Reason for failure: The feedback from the patients indicated that the crutch bar was 
exerting pressure on the medial portion of the eyelid and that they were having trouble 
blinking [Figure 24]. 
Concept 2: To overcome these design flaws, the design was iterated to include two 
units joined by a spring. The idea was that the curved bars would be attached together 
via a spring [Figure 25]. The bars would pull the eyelid upwards, thus elevating it above 
the visual axis. When the user initiated a blinking force the lower bar would ‘give’ and 
move down with the eyelid while the upper bar maintained a fixed position at the level 
of the eyelid crease. When the blinking contraction ceased, the lower bar would return 
to the upper bar via the spring mechanism. 
Figure 24. A myasthenia gravis patient wearing an early design of the ptosis crutch, on the left eye. 
Although the ptosis crutch elevated the eyelid it disrupted the blinking mechanism. The crutch failed to 
adjust along the z axis. 
Figure 25. A model of the double bar ptosis crutch. The concave crutch bars were connected by a 
spring mechanism. 
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Reason for failure: the design was too bulky. A method of using a single bar to allow 
for blinking to occur was be investigated.  
Concept 3: Following the rejection of the double bar design, the single curve was 
readopted and refined. The bar was further curved along the z-axis to mimic a natural 
eyelid contour as well as allowing the crutch to make contact with the eyelid at a slightly 
lower position on the lateral side.  
Reason for failure: The bar applied excessive pressure to the globe, thus disrupting 
the blinking mechanism. 
Concept 4: The crutch bar was iterated to include a flexible eyelid contact surface 
rather that the rigid bar [Figure 26]. The flexible bar was a combination of a galvanized 
wire that was coated in polyvinyl chloride tubing. The galvanized wire was moulded to 
fit the shape of the globe. The wire maintained the structural integrity of the crutch bar 
while the PVC ensured that the bar depressed and elevated with the blink of the eye. 
Additionally, the PVC tubing provided good skin-crutch bar coupling. A full description 
of how the crutch bar was prototyped can be found in section 4.2. 
Reason for failure: The reason for failure was a result of the attachment position (see 
section 3.15) 
 
Concept 5: The crutch bar generated as concept 4 was used. The iteration involved 
the attachment point to the spectacle frame.  
Figure 26. The crutch bar positioned on the upper eyelid. The concave crutch bar makes full contact 
with 20mm of the eyelid, at the centre of the horizontal palpebral fissure. The contact between the 
crutch bar and the eyelid tapers off on the outer edges of the horizontal palpebral fissure length. 
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3.15 Attachment to spectacle frame 
Concept 1: The first concept was to design a spectacle temple that incorporated the 
ptosis crutch. This design involved removing the existing temple from the spectacles 
and attaching the temple housing the fixed crutch. The initial appeal of this design was 
the secure attachment of the crutch to the spectacles. The concerns with this concept 
were that 1] the adjustment along the Y-axis would cause complications and 2] the 
attachment/detachment of the crutch would be timely. 
Concept 2: The shortcomings of the first concept were overcome by simplifying the 
attachment of the ptosis crutch fitting on to the existing spectacle temple rather than 
replacing the temple in its entirety. This design allowed the crutch to be adjusted along 
the x, y and z-axes. 
Several iterations were made to the spectacle temple attachment component (see 
Appendix 2.4 for details). 
Reason for failure: The attachment worked well and adjustment along the x and y-
axes functioned as intended. The adjustment along the z axis had been designed via 
a rotational control [Figure 27]. The rotational control aimed to adjust the amount of 
eyelid elevation by moving the crutch bar over the eye globe i.e. following the contour 
of the globe. The problem with this design was that the crutch was attached to the 
temple of the glasses, thus when the control was rotated the crutch pivoted on the 
eyelid and pushed the spectacles off the nose of the user. 
Concept 3: The rotational control was iterated to include a control that moved the 
crutch along the y-axis and secured the crutch position according to fixed intervals 
[Figure 28].  
Figure 27. A model of a failed crutch bar design that was adjusted along the z-axis using a rotational 
control.  
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Reason for failure: Although the device was functional, it was not performing 
optimally as the amount of elevation required could not be categorized into fixed 
intervals. 
Concept 4: The difficulties incurred with attaching the crutch to the spectacle temple 
suggested that a new approach needed to be adopted. The proposed solution was to 
change the location of crutch attachment. It was decided that the crutch would be 
attached to the superior border of the spectacle. The new site of attachment allowed 
the crutch to pull the eyelid towards the origin when elevating the eyelid, thus making 
the design biomechanically sound. 
 3.16 Globe projection component iterations 
The ptosis crutch was required to accommodate for the difference in globe projection 
between users.  
Concept 1: The initial concept was a slide design that moved the crutch bar along the 
y-axis [Figure 29].  
Reason for failure: The design satisfied the requirement of y-axis adjustment, 
however, the method of securing the slide component when in the correct position was 
unclear. 
Figure 28. The rejected crutch attachment that adjusted the elevation provided by the crutch. The 
design was rejected as the amount of elevation required differs between individuals and cannot be 
categorized into fixed intervals. 
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Concept 2: A second method of adjusting along the y-axis was designed whereby the 
crutch bar was positioned in different slots on the housing component [Figure 30].  
Reason for failure: The design was rejected as it only allowed the crutch to be 
adjusted according to the predefined fixed intervals. The inter-individual variability of 
globe projection could not be accurately categorized into fixed intervals and therefore 
the crutch would not cater for the entire patient population.  
Concept 3: The slide mechanism was readopted. The relocation of the attachment, 
to the superior border of the spectacles, allowed the slide mechanism for the 
adjustment of globe projection to be maintained.  
Figure 29. A model of an early design for y axis adjustment. The method of securing the slide adjustment 
to the spectacles was unclear. The design was iterated and later readopted. 
Figure 30. The rejected crutch attachment that adjusted for globe projecion by fixed intervals. The 
design was rejected as globe projection differs webteen indiciduals and cannot be categorized into fixed 
intervals.  
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3.17 Additional considerations 
The horizontal position, as well as the obliquity of the eye, were additional design 
requirements that lead to the iteration of the ptosis crutch components. The design 
iterations associated with each of these device requirements are discussed in detail 
below. 
3.17.1 Horizontal position of the eye 
Adjusting the ptosis crutch bar along the x-axis was necessary to allow for the inter-
individual difference in the horizontal position of the eye.  
Concept 1:  The crutch bar was adjusted along the x-axis using a thread mechanism 
[Figure 31].  
Reason for failure: The concept worked well in a scaled-up model of the device, 
however, 3D printing a thread of the required size was not possible using the available 
resources.  
Concept 2: The crutch bar was adjusted along the x-axis using a zip tie mechanism. 
The crutch bar was pushed along the x-axis, until it was correctly positioned above the 
eye crease. The protruding portion of the crutch bar was snipped off. 
Reason for failure: 3D printing a zip tie mechanism with the required precision was 
not possible using the available resources. 
Figure 31. A model of the thread mechanism to adjust the horizontal position of the ptosis crutch along 
the x axis. The design was rejected as 3D printing a thread of this size was not possible. 
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Concept 3:  The crutch bar was adjusted along the x-axis using a press fit mechanism. 
When the crutch bar was correctly positioned above the crease of the user’s eyelid, 
the protruding end of the crutch bar was snipped off.  
Reason for failure: The relocation of the ptosis crutch attachment from the spectacle 
temple to the superior border of the spectacle frame required an alternative method of 
x-axis adjustment.  
Concept 4: The ptosis crutch was adjusted along the x-axis by clipping the attachment 
component onto the spectacle frame at the position above the user’s eyelid crease.  
3.17.2 The obliquity of the crutch bar 
It has previously been suggested that it is difficult to measure the fissure obliquity of 
ptosis patients, due to the obstruction to the palpebral aperture (Moorfields Eye 
Hospital, 2015). The first generation of the crutch curve was tangent to the x and y-
axes. As was expected the crutch did not make full contact with the eyelid and when 
the eyelid was elevated it caused the eyelid to adopt an unnatural contour. The design 
was iterated to include an offset of 1mm and 2mm along the z and x-axes respectively. 
The offset was designed to cater for an upward sloping palpebral fissure. During the 
clinical testing of the ptosis crutch, it was evident that upward sloping crutch bar was 
not compatible with all of the participants as there were participants that had a 
downward sloping aperture. This finding was supported by previous studies, which 
have illustrated that the direction and degree of the palpebral slant differ between 
individuals (Odunze, et al., 2008). The crutch was further iterated to include an upward 
and downward inclination of the crutch bar.  
 
45 
4. Design Outcome 
This chapter presents the results of the final ptosis crutch design. The results were 
analysed and interpreted. A discussion of the results is presented in Chapter 5.  This 
chapter is divided into subsections according to the design and the clinical 
methodologies.  Subsection 4.1 illustrates the ptosis crutch design outcome with 
relevant CAD drawings and models. Subsection 4.2 is focussed on the clinical testing 
of the ptosis crutch. The eyelid elevation provided by the crutch as well as initial 
qualitative feedback from the participants is displayed.  
4.1 Final ptosis crutch design 
The final ptosis crutch, displayed in Figure 32, was comprised of three separate 
components; the crutch bar, the housing and the control. The ptosis crutch 
requirements and corresponding design features are summarized in Table 7. 
Table 7. The design requirements of the ptosis crutch with the corresponding design features of the 
final design. 
Design Requirements Design Features 
Elevate the upper eyelid above the 
visual axis. 
The curved crutch bar pulls the eyelid in a vertical direction to 
clear the visual axis. 
Adjust for the variation in eyelid 
elevation 
The crutch has vertical adjustment along the z-axis, allowing 
for variation in the degree of ptosis. 
Attach to spectacles 
The crutch is attached to the superior border of the spectacles 
via a clip mechanism. 
Modular 
The ptosis crutch is categorized into three functional 
components, namely the crutch bar, the globe projection 
control as well as the attachment to the spectacle frame.   The 
globe projection control is responsible for connecting the 
crutch bar to the attachment component. 
Adjust for globe projection 
The crutch has a slide mechanism along the y-axis, allowing 
for variation in globe projection. 
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4.1.1 Functionality 
The intended function of the device is to elevate the droopy eyelid(s) of MG patients. 
The device elevates the upper eyelid. The ptosis crutch elevates the eyelid by applying 
upward and backward pressure on the eyelid. The crutch is positioned on the eyelid, 
just above the upper eyelash margin. The crutch bar maintains continuous contact 
with the upper eyelid, while it is elevated to the appropriate position using the vertical 
lever. The ptosis crutch can be adjusted by the user to fit the globe projection, by 
sliding the connection component along the y-axis. The adjustable components enable 
the ptosis crutch to be fitted according to the patient’s individual requirements, thus 
making the device patient specific. 
Patients that do not wear spectacles were issued with a pair of spectacle frames with 
clear glass lenses, to which the crutch was attached. Should the user no longer require 
the ptosis crutch it can be detached by the user and the spectacles will be restored to 
their original state. 
4.1.2 Prototyping 
The final ptosis crutch was prototyped using a combination of 3D printing and manual 
manufacturing. The method of prototyping the components is tabulated in Table 8. 3D 
printing was the primary methodology of prototyping the ptosis crutch, as it is a low-
cost prototyping method for a device of this size (Berman, 2012).  
Figure 32. A model of the ptosis crutch. The arrows indicate the direction of movement that each 
component allows. 
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The concave crutch bar was manually moulded using 1.5mm galvanized wire. The 
crutch bar was coated in polyvinyl chloride (PVC) tubing. The tubing used to coat the 
crutch bar was from an Alaris©Products extension set, a Food and Drug 
Administration (FDA) approved product. The PVC tubing containing the crutch was 
threaded through the crutch bar housing component, after which it was cut to size and 
secured in position using steel pins. The steel pins were manufactured by sanding 
2mm steel nails to size. A visual illustration of the crutch bar assembly is provided in 
Figure 34.  
Table 8. The three modular components of the ptosis crutch and their respective prototyping methods. 
Although the manufacturing of the ptosis crutch was simple and the initial patient 
feedback has been positive [see section 4.2], it is important to highlight the challenges 
that were faced during prototyping the device. The 3D printer was unable to print the 
parts according to a consistent size, the ambient temperature and the colour of the 
ABS filament greatly impacted the quality and consistency of the print. Despite the 
CAD model being scaled appropriately to accommodate for the 0.05mm variability of 
the 3D printer, there was an unknown margin of oversized components that needed 
to be filed down.  
After the components had been filed down, hot air was used to restore the original 
colour of the ABS. Finally, acetone vapour based smoothing was applied to the 3D 
printed components to remove any rough edges and provide a smooth appearance. 
Despite the improved aesthetics of the components after acetone vapour based 
smoothing, the parts were considerably more flexible. This proved to me problematic 
for the attachment component that required a certain degree of rigidity in order to 
Component Prototyping method 
Attachment to spectacles 3D Printed 
Globe projection control 3D Printed 
Crutch bar  
1. Housing 3D Printed 
2. Curved crutch Galvanized wire coated with polyvinyl chloride tubing 
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effectively clip onto the spectacle border. Through trial and error, it was found that 
satisfactory surface smoothing was obtained when the control and crutch bar housing 
were placed in the acetone chamber for 20 minutes while the attachment component 
was placed in the chamber for 10 minutes. The acetone chamber is illustrated in Figure 
33. 45 ml of acetone was placed on the lining of the chamber prior to inserting the 
components.  
Using the described prototyping methods, a single ptosis crutch unit is estimated to 
cost R13 (± 0.90 USD, at the time of the study) to manufacture. This is considerably 
less than the cost of existing ptosis crutch devices, which are reported to cost between 
30 – 100 USD (World Optic, 2016; Porter & Salter, 2005; Pelak, et al., 2001). 
Alternative methods of manufacturing were researched (press and die and laser 
cutting). Despite the minor constraints of 3D printing the ptosis crutch, it was evident 
that the benefits of using 3D printing as the method of prototyping outweighed the 
costs.  
Figure 33. The acetone chamber with the device components placed on the aluminimum platform. The 
acetone is applied to the cloth using a syringe. The chamber is then placed over the aluminium platform 
for 10 – 20 minutes. The acteone vapour based smoothing is a process that gives the ABS plastic a 
smooth and glossy appearance.  
4
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4.1.3 Adjusting the ptosis crutch to fit the user 
The attachment component is adjusted to the specifications of the user’s spectacle 
before manufacturing, The CAD model of the attachment component is tweaked 
according to the dimensions of the patient’s spectacle border. Adjusting these 
dimensions before the component is 3D printed ensures that the ptosis crutch is firmly 
attached to the spectacles. The dimensions that are adjusted are displayed in Figure 
35. The crutch bar and globe projection control are standard components that are 
adjusted when fitting the crutch to the patient. Figure 36 illustrates the ptosis crutch 
being fitted to a participant. 
The ptosis crutch will be made available on an open source platform in a manner that 
is easy to fabricate using a common 3D printing setup, i.e. STL files with simple 
instructions. The reason for making the device available on open source was to 
increase the accessibility of the crutch to ptosis patients as well as interested 
institutions. The open source platform and its potential benefit for the users are further 
discussed in Section 5. 
Figure 35. A drawing illustrating the dimensions of the attachment that are altered according to the 
height (H) and width (W) of the spectacle frame. The dimensions are altered in SolidWorks before the 
file is exported in STL format. The institution where the device will be 3D printed should be able to 
adjust these dimensions for the user, should the user not have access to the SolidWorks software.  
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4.1.4 Failure Mode Effects Analysis 
FMEA is a systematic approach for evaluating a product to identify the areas and 
reasons where failure may occur (Institute for safe medication practices, 2016). In the 
context of this study, each component of the ptosis crutch was evaluated to identify 
potential areas of failure. The FMEA of the ptosis crutch is displayed in Table 11. The 
severity and occurrence of the failure were assigned subjective ratings by the 
designer. A description of each of the ratings is provided in Table 9 and Table 10.   
Table 9. The description of the FMEA severity ratings 
Minor  
(Rank 1) 
Low  
(Rank 2) 
Moderate  
(Rank 3) 
High  
(Rank 4) 
Very high 
 (Rank 5) 
The failure will have 
no noticeable effect 
on the performance 
of the device. The 
user will most likely 
not be able to detect 
the failure 
The user will 
experience slight 
annoyance as a 
result of the failure. 
The user will notice 
a slight 
inconvenience 
when using the 
device. 
Failure causes 
some user 
dissatisfaction 
which may include 
discomfort or 
annoyance. The 
performance of the 
device is 
compromised 
High degree of 
user 
dissatisfaction 
due to the nature 
of the failure.  
Failure may 
result in serious 
hindrance to the 
performance of 
the device 
Failure affects 
the safety of the 
user. The device 
will not perform 
its function as 
intended. 
 
 
 
Table 10. The description of the FMEA occurrence ratings. 
Remote 
 (Rank 1) 
Low  
(Rank 2) 
Moderate 
 (Rank 3) 
High 
 (Rank 4) 
Very high 
 (Rank 5) 
Failure unlikely. No 
failures of this 
nature have been 
reported 
Isolated 
failures 
Occasional 
failures 
Often occurring 
failures 
Inevitable failures 
Figure 36. A photograph illustrating the ptosis crutch being fitted to the participant’s spectacle frame 
for permanent use. 
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4.2 Clinical results 
Clinical testing was carried out before and after the ptosis crutch design process. 
Outside of these formal testing sessions, the various designs were presented to the 
participants and the clinician. Both parties expressed their thoughts on the 
components of the crutch that needed further development. In this manner, the design 
was fed through continuous iterations, informed by the participants, clinician as well 
as the designer. 
The pre-design testing intended to gain anthropometric measures to inform the design 
specifications. Additionally, questionnaires were completed by the participants to gain 
insight into the effect that ptosis had on the visual function, activities of daily living and 
quality of life of the patients.  
The post- design clinical testing aimed to quantify the functionality of the ptosis crutch. 
Furthermore, the subjective effect of the crutch on the participant’s visual ability as 
well as the ease of use and aesthetic appearance of the crutch, was determined.  
4.2.1 Pre-design anthropometric measurements 
The measurements recorded in the pre-design testing included the resting position of 
the upper eyelid in primary position and the HPF [Table 12]. Additionally, the patients 
were required to complete a questionnaire regarding the initial user experience.  
16 MG patients volunteered to participate in the study. The mean MRD measurement 
was -1.44mm (±2.17mm), for 32 eyes. There was no difference in the values for 
manual and digital measurement [Figure 37]. The digital measurement values were 
used to inform the design parameters.  
Table 12. The pre-design anthropometric measures of 16 MG patients. 
 
Marginal reflex 
distance (mm) 
Vertical palpebral 
fissure (mm) 
Horizontal palpebral 
fissure (mm) 
Corneal 
diameter (mm) 
x -1.44 4.23 22.83 10.6 
SD 2.17 2.31 3.02 0.48 
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4.2.2 Predesign qualitative results 
The purpose of the qualitative assessment was to determine the impact that ptosis 
has on the participants, visual field, activities of daily living and quality of life. 
With reference to the results displayed in Table 13 Visual function, specifically, the 
superior field of vision, was reported as poor. The patients perceived their eyelid 
appearance as being fair.  
Table 14 displays a comprehensive overview of the perceived impairment that ptosis 
has on the participant’s ability to complete activities. The activities that were perceived 
as having the greatest impairment included reading, watching television as well as 
walking up/down stairways. The activities that were least affected were identifying 
objects as well as shaving and styling hair. 
Figure 37. The vertical palpebral fissure (VPF) values measured using manual and digital methods. 
There was no significant difference between the two methods of measurement (p>0.05).  
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Table 13. Mean scores of the impairment that ptosis has on symptoms in a group of 16 myasthenia 
gravis patients. 
Symptom No. Responses1 Mean Score Mode 
General visual function 14 3 4 
Superior visual field 14 4 4 
General health 14 2 2 
Eye or eyelid appearance 14 3 3 
1.No. responses refers to the number of respondents 
 
Table 14. Mean scores of the impairment that ptosis has on activities in a group of sixteen myasthenia 
gravis patients. 
Activities 
No. 
Responses1 
Mean Score Mode 
Reading 15 3 3 
Watching television 12 3 4 
Working on a computer 6 3 4 
Walking up/down steps or around curbs 15 3 1 
Identifying objects 15 1 1 
Hanging or reaching objects 13 2 1 
Performing occupation 7 1 1 
Shaving, styling hair 14 2 1 
1.No. responses refers to the number of respondents 
4.2.3 Ptosis crutch clinical testing 
Functional testing of the ptosis crutch was performed within the clinical testing. The 
amount of eyelid elevation that the ptosis crutch provided was measured using the 
same experimental setup that was used for the pre-design testing. The values for 
manual and digital measurement were found to be the same (p< 0.05) [see section 
3.1.4]. Previous studies have reported similar results, thus the decision to only perform 
digital analysis for the final crutch testing was justified (Coombes, et al., 2007).  
12 patients volunteered to take part in the post-design testing. Figure 38 displays the 
MRD of the participant’s eyes when unassisted and when wearing ptosis crutch. The 
mean pre-crutch MRD measurement was -0.83 (±1.38mm), for 19 ptotic eyes. The 
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measurement differs from the MRD recorded in the pre-design clinical testing as ptosis 
associated with MG is variable in nature.  
The MRD when wearing the ptosis crutch was 0.86mm (±1.33mm) compared to -
0.83mm (±1.38mmmm) for 19 ptotic eyes. The difference in the MRD resulted in 
1.69mm (±1.15mm) of elevation to the upper eyelid. The difference in the MRD 
between the two conditions was significant [Table 15]. 
Table 15. One- Way ANOVA of the Marginal Reflex Distance between wearing a ptosis crutch and 
when not wearing a ptosis crutch; measured on 19 ptotic eyes. 
 
Effect SS Degr. of MS F p 
Intercept 0.00007 1 0.00007 0.00003 0.995317 
Condition 29.76255 1 29.76255 15.79975 0.000324 
Error 67.81448 36 1.88374   
Figure 38. The marginal reflex distance (MRD) without the aid of the ptosis crutch and while wearing 
the ptosis crutch, recorded from 12 patients (19 ptotic eyes). 
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The results of the additional measurements that were recorded during the clinical 
testing of the ptosis crutch can be found in Table 16. The increase in the MRD and 
VPF when wearing the ptosis crutch compared to when not wearing the ptosis crutch. 
Table 16. The marginal reflex distance (MRD), vertical palpebral fissure (VPF) and horizontal palpebral 
fissure (HPF) measurements for 12 myasthenia gravis patients with and without the ptosis crutch. 
 
No Crutch Crutch 
 
MRD (mm) VPF (mm) HPF (mm) MRD (mm) VPF (mm) HPF (mm) 
X -0.83 4.72 18.67 0.86 5.96 24.11 
SD 1.38 2.34 7.05 1.33 1.86 4.28 
 
 
 
4.2.4 Qualitative assessment during the clinical testing 
The purpose of the qualitative assessment was to gain initial patient feedback on the 
functionality of the ptosis crutch as well as the comfort, aesthetic appearance and the 
willingness to use the device. 
Table 17 displays the participant’s feedback on the ptosis crutch, during the testing 
session. All of the participants indicated that the crutch did not cause and pain or skin 
irritation during the testing session. While all of the participants indicated that they 
were interested in using the ptosis crutch on a long-term basis, there was a concern 
about the aesthetic appearance of the device, particularly from the younger 
participants.  
Table 17. Mean scores of the feedback on the ptosis crutch in a group of 12 myasthenia gravis patients. 
The responses were recorded from a questionnaire administered during the clinical testing of the ptosis 
crutch. 
Characteristic 
No. 
Responses 
Mean Score Mode 
Comfort 12 4 4 
Visual Function 12 5 5 
Ability to blink 12 4 4 
Ease of attachment 12 4 4 
Fit (congruency of crutch curve to the shape of 
the globe) 
12 4 5 
Eyelid/eye appearance 12 4 4 
1.No. responses refers to the number of respondents 
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4.2.5 Usability of the ptosis crutch 
The usability feedback from the 8 MG patients that had been using the crutch for a 
month or longer reflected a variety of results. The outcome of the usability testing is 
presented in Table 18.   
Table 18. The ptosis crutch frequency of use by 8 participants. The frequency of use was reported after 
the participants had been using the crutch for a minimum of one month.  
Frequency of crutch use Number of patients 
Used full time 0 
Used occasionally (4 hours per day) 6 
Used minimally (<4 hours per day) 2 
Not used 0 
 
The reasons for non-use included 1] the crutch broke, 2] wearing the crutch caused 
the eye to tear, 3] The user was not accustomed to wearing the crutch/wearing glasses 
and 4] the user had trouble adjusting the crutch appropriately thus the crutch was 
uncomfortable to wear for long periods of time. 
The reasons noted for occasional and minimal used included 1] the patient was not 
yet accustomed to wearing the ptosis crutch, 2] the patient’s eyes were watering when 
the eyelid was elevated. 
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5. Discussion of the Design Outcomes 
The design of the ptosis crutch was successful, in that all of the requirements were 
met. The functionality of the ptosis crutch prototype was tested within the clinical. Initial 
feedback on the crutch was noted during the clinical testing as well as after the crutch 
had been used for a minimum of one month.  
5.1 Functionality 
12 MG patients tested the functionality of the ptosis crutch, within the clinical setting. 
The initial feedback on the device showed a promising outcome for the device.  
5.1.1 Eyelid elevation 
The ptosis crutch increased the MRD of the ptotic eyelid by 1.69mm (± 1.66mm). The 
elevation is sufficient to clear the visual axis in ambient lighting conditions when the 
diameter of the pupil is 3-4mm [see section 2.4.1]. During the clinical testing of the 
crutch, the eyelid was not elevated to a maximum position [Figure 39]. The reason for 
only elevating the eyelid to clear the visual axis was to ensure that the blinking 
mechanism was not disrupted. Additionally, the participants experienced tearing of the 
eye when the eyelid was elevated above the necessary position. It is thought that the 
tearing of the eye will settle down as the user becomes accustomed to the device.  
The reason for reporting the MRD as the primary indicator of the upper eyelid position 
is due to the inter-individual variability of the position of the pupil within the eye 
aperture. 
5.1.2 Adjustability 
The device is adjustable along the x, y and z-axes. The described method of 
adjustment along the z-axis was effective but cumbersome. The mechanism requires 
a portion of the component to be visible above the superior border of the spectacle 
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frame [Figure 40]. Operating the mechanism requires the user to exert a pinch grip on 
the lever and push or pull the crutch in the desired direction.  
The mechanism that allows the device to be adjusted along the y-axis, requires the 
user to slide the control along the y-axis as described in section. Once in the correct 
position the control is snipped and fixed in position. As previously mentioned [see 
section 2.3] there is no evidence of a ptosis crutch that provides the user with the 
autonomy to fit and adjust the crutch themselves. Although simple, the method of 
adjusting and securing the crutch, when fitting the crutch for the first time, requires a 
certain amount of patience and finesse. The user will need to pay careful attention to 
the instructions that accompany the open source file in order to ensure that the device 
is secured and adjusted correctly. 
5.2 Anthropometric measures 
In addition to the MRD, several other anthropometric measures were taken. The effect 
that the ptosis crutch had on the VPF and HPF distances, as well as the shape of the 
eyelid contour, are discussed below. 
A 
B 
Figure 39. Photographs of a participant A] without the aid of the ptosis crutch and B] with the ptosis 
crutch attached to the spectacle frame provided by Muller’s Optometrists. 
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5.2.1 Vertical palpebral fissure 
The VPF was recorded despite it not being the primary measurement for determining 
eyelid elevation. The VPF increased significantly when wearing the ptosis crutch 
compared to when the ptosis crutch was not worn (p<0.05). Although interesting, the 
increase I the VPF does not indicate whether the visual axis was cleared as the 
measurement does not consider the position of the pupil. 
5.2.2 Horizontal palpebral fissure 
The HPF showed a significant increase in length when wearing the ptosis crutch, 
compared to when the ptosis crutch was not worn (p<0.05). With this in mind, it is 
important to note that the HPF when wearing the ptosis crutch was still less than that 
described in the literature (Barretto & Mathog, 1999).  
5.2.3 Eyelid contour 
The eye contour varies between individuals. Previous studies have indicated that the 
position and height of the peak of the eyelid margin as well as the length and obliquity 
of the fissure, influence the appearance of the eyelid contour (Beden & Beltram, 2012). 
The device described herein acknowledged that both upward and downward sloping 
fissures exist in that both upward and downward slanting designs are available. The 
design is based on the normal fissure obliquity of ± 1.5mm. Should the fissure obliquity 
of the user differ from this value, the slant of the crutch bar can be adjusted in 
SolidWorks.  
Figure 40. The ptosis crutch elevating the right upper eyelid of the user. The vertical lever used, used 
to control the degree of elevation offered by the ptosis crutch is visible above the spectacle border. The 
reason for using a 25mm lever was twofold; firstly, to allow the crutch to cater for the variability in the 
degree of eyelid elevation required. Secondly, it provided a large enough surface area for the user to 
find a firm grip to adjust the eyelid elevation.  
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 5.3 Technical challenges 
Several technical challenges were incurred during the design and prototyping of the 
ptosis crutch [Table 19]. The challenges were overcome through the iterative design 
process that was described in section 3. 
Table 19. The technical challenges incurred during the design of the ptosis crutch. 
 Technical Challenge 
1 3D printing the device 
2 Ensuring that some blinking effort is possible 
3 Allowing for adjustment along the x, y and z-axes 
4 Aesthetics of the device 
 
The device described herein was intended to be a standard solution ptosis crutch 
design rather than an ad-hoc device. For the most part the device fulfilled this 
requirement, however, there were three circumstances that required the design to be 
altered to cater to the specific needs of the user.  
Case 1 
The participant’s spectacle frame had a 12° curve. The CAD model of the attachment 
was altered to include a curve along the x-axis [Figure41]. The crutch bar and control 
were not altered.  
 
 
Figure 41. A model of the attachment component that was altered to include a 12-degree curve along 
the x axis in order to ensure a secure clip onto the user’s spectacle frame. 
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Case 2 
The participant’s spectacles did not fit securely on the nasal bridge. As a result, the 
glasses slipped down the nasal bridge when the crutch was positioned on the eyelid. 
This resulted in the crutch applying superior pressure to the eyelid and thus closing 
the eye. The spectacles need to be tightened by an optometrist before the crutch can 
be fitted comfortably. 
5.4 Visual function and activities of daily living 
The qualitative assessment aimed to determine the effect (if any) that wearing the 
ptosis crutch on the user’s ability to perform activities of daily life. The initial patient 
feedback on the ptosis crutch shows a promising outcome for the ptosis crutch. The 
qualitative questionnaire [Appendix 1.3] assessed the comfort, effect on the visual 
axis, ability to blink, among other factors.  
5.5 Comparison to existing ptosis crutch devices 
All of the existing ptosis crutches refer to a crutch design that requires the practitioner 
to custom fit the crutch to the patient’s spectacles. The crutch is permanently mounted 
to the user’s spectacle frame or lens. Unfortunately, custom making crutches require 
the patient to have access to the appropriate facilities as well as the funds to supports 
this option, a criterion that is often not available to a large portion of the South Africa 
population.  Although the ptosis crutch itself is not a new idea, none of the filed patents, 
scientific literature or practitioner designs are similar to our invention in that they are 
not modular or adjustable in nature.   
As indicated by the literature ptosis associated with MG is predominantly an African 
clinical problem. There is no evidence of a ptosis crutch that has been designed and 
produced in South Africa or the African continent as a whole. Previous studies support 
the idea that there is an unmet need for a low-cost, non-invasive device that alleviates 
the symptoms of ptosis (Jin Tan, et al., 2012; Lamina & Hanif, 2009; Walsh, et al., 
2006).  
The specific differences between the proposed ptosis crutch design and the existing 
ptosis crutch devices are outlined below: 
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5.5.1 Modular  
The ptosis crutch is modular in design in that the design is compartmentalized into 
functional components. The specific components as illustrated in Figure 42 include; 
the crutch bar (A), the crutch housing (B) and the attachment component to the arm 
of the glasses (C).  
5.5.2. Adjustable 
The ptosis crutch is adjustable along the x, y and z-axes. The amount of globe 
projection varies between males and females, as well as across racial groups [see 
section 2.4.7]. The differences in globe projection stimulated the need for the crutch 
to be adjustable along the y-axis.  
The distance between the medial canthus and the nasal bridge differs between 
individuals. It was, therefore, important for the crutch to be adjustable along the x-axis. 
The adjustability is achieved through the position of attachment on the spectacles.  
The crutch is clipped onto the spectacle border above the patient’s eye crease.  
The crutch bar is adjustable along the z-axis. The crutch bar is adjusted to elevate the 
eyelid 2-5mm to clear the visual axis. The adjustable component of the crutch is 
particularly beneficial to MG patients, as they experience fluctuating severity of ptosis 
throughout the day and during the course of the disease. 
 
A B C 
Figure 42. The modular components of the ptosis crutch. A] Crutch bar. B] Control and connection 
between the spectacle attachment and the crutch bar. C] Attachment to spectacles. 
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5.5.3. Material selection 
Previous ptosis crutch devices have been manufactured using metal wire (stainless 
steel, bronze, gold or copper-aluminium) or nylon. User feedback on these designs 
indicated that the wire exerts pressure on the globe, resulting in double vision as well 
as causing skin irritation at the site of crutch-eyelid contact. The ptosis crutch 
described by this research was prototyped using a combination of ABS and a 
galvanized wire covered in PVC tubing. The PVC coated crutch bar allows for good 
skin-crutch coupling and no skin irritation has been reported by the patients.  
5.5.4. Affordability 
The ptosis crutch prototype, described by this project, cost 0.9 USD per unit to 
produce. This is markedly lower than the 30 – 100 USD cost of existing devices on the 
market (World Optic, 2016; Porter & Salter, 2005; Pelak, et al., 2001). The project is 
currently undergoing the necessary procedures towards launching the ptosis crutch 
on an open source innovation platform. This will ensure that the ptosis crutch is easily 
available, by allowing ptosis patients or interested institutions to download the ptosis 
crutch STL file free of charge. 
5.5.5. Ability to blink 
The ptosis crutches that have previously been used often interfere with the patient’s 
ability to produce any blinking effort, resulting in the patient experiencing cornea 
drying. The blink mechanism may be inhibited by one of two reasons; the crutch may 
Figure 43. A superior view of the ptosis crutch attached to the right and left sides of the spectacle 
frame. The spectacles are setup to elevate the eyelids of a person with bilateral ptosis. 
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exert an upward force that is too great for the muscles involved in eye closure to 
overcome or the crutch positions the eyelid at an ‘over-elevated’ position. The ptosis 
crutch described in the current project has been manufactured using materials with 
sufficient flexibility to allow for some blinking effort to occur. It is important to note that 
the crutch does not elevate the crutch to a ‘normal’ anatomic position but rather to a 
position that is just enough to clear the visual axis. 
5.6 Socio-economic impact 
MG affects individuals of all racial groups, however, the outcome to therapy of the 
disease differs across races. Patients of African genetic ancestry, particularly 
juveniles, are more likely to develop ocular muscle complications of MG when 
compared to their European counterparts. Despite the presentation of ptosis in MG 
patients, there is no record of a crutch that has been designed for the MG population. 
Surgical correction of ptosis is possible; however, it is often contraindicated in MG 
patients with severe weakness of the muscles involved in eye closure and in patients 
with active disease. In these cases, a non-surgical solution to elevating the ptotic 
eyelid above the visual axis is required.  
The association of treatment resistant and ocular muscle complication in MG patients 
of African ancestry emphasizes the need for a local, low-cost solution to elevate the 
eyelid. This need is not isolated to Africa as there appears to be an unmet need for 
such a device in developing countries worldwide (Jin Tan, et al., 2012; Lamina & Hanif, 
2009).  
Figure 44. A ptosis crutch unit fitted to the superior border of two different spectacle frames. 
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The ptosis crutch described by this project provides an important step in offering a 
standard rather than an ad-hoc solution to elevating the ptotic eyelid of MG patients. 
The ptosis crutch design offers a standardized manufacturing method for the ptosis 
crutch. The device will be made available on an open source innovation platform. This 
will ensure that the ptosis crutch is easily available, by allowing ptosis patients or 
interested institutions to download the ptosis crutch STL design file free of charge.  
Although, the device described herein is a solution to alleviating ptosis associated with 
MG, the application of the ptosis crutch could be of use to individuals with ptosis of 
other aetiologies. 
5.7 Usability requirements 
The usability requirements of effectiveness, efficiency and user satisfaction were 
explored to determine whether the ptosis crutch could be considered as successful in 
meeting the needs of the user. Each of these components is outlined in detail below.  
5.7.1 Effectivity 
Effectivity was defined as the ability of the ptosis crutch to effectively elevate the upper 
eyelid to clear the visual axis. The ptosis crutch was successful in elevating the eyelid 
to clear the visual axis. There were circumstances where the ptosis crutch needed to 
be altered to the specific requirements of the user [see section 5.3]. While the clinical 
testing of the ptosis crutch showed a promising outcome for the device, it is ultimately 
the long-term feedback on the device that will provide a more valuable indication on 
the usability of the device.   
5.7.2 Efficiency 
The efficiency of the ptosis crutch describes the device’s use of resources. The term 
resources referred to the materials and manufacturing methods that were utilized. The 
ptosis crutch can be considered as efficient as it cost a 0.9 USD to produce. This is 
noticeably less than the rate of existing devices, which cost between 30-100 USD 
(World Optic, 2016; Porter & Salter, 2005; Pelak, et al., 2001).  
5.7.3 User satisfaction 
User satisfaction describes the user’s subjective feeling of the ptosis crutches 
usefulness. The device needed to meet the user’s performance expectations as well 
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as being comfortable and easy to use. For the purpose of the current study, it was 
important to communicate to the participants that the ptosis crutch was not intended 
to restore the functionality of the muscles involved in eyelid elevation, but rather to act 
as an aid to manually elevate the eyelid in order to improve their visual function. 
 The initial feedback from the participants indicated that the ptosis crutch improved 
their vision. The participants reported the device as being comfortable and indicated 
that they were interested in using the device on a long-term basis.  
The participant feedback after the crutch had been used for a minimum of one month 
showed mixed results. One participant found the crutch useful when reading and 
completing tasks around the house. Four participants indicated that they were no 
longer using the crutch as it had broken, however when they had been wearing the 
crutch, they had found it to be useful. Two participants indicated that they were not yet 
accustomed to wearing the ptosis crutch. One participant indicated that they were 
experiencing tearing when their eyelid was elevated. It is thought that manufacturing 
the device with more durable materials will improve the adjustment mechanisms as 
well as resulting in fewer crutch breakages.
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6. Conclusions and Future Work 
The present study sought to design a low cost, modular and adjustable ptosis crutch 
for the MG patient population. Although the ptosis crutch is not a new device, the final 
crutch described herein has several novel aspects. The design of the ptosis crutch 
followed a bottom-up design strategy, in that the design was continuously iterated with 
the input from the users, clinician and designer.  
The use of ptosis crutches in South Africa has been limited due to cost, device scarcity 
and poor patient - device compatibility. Furthermore, no evidence was found of a ptosis 
crutch that is designed specifically for the MG population. The motive for developing 
an MG patient specific crutch was due to the patients not being candidates for surgery. 
The variable nature of ptosis associated with MG further supported the need for the 
development of the ptosis crutch described within this study. The device described 
herein is a simple, cost effective solution that has had positive initial feedback from the 
users. 
This study suggests that the use of the ptosis crutch results in a reported improvement 
in the visual field as well as an improvement in several aspects of subjective visual 
function. The ptosis crutch appears to offer a step in the right direction to improving 
the visual function and quality of life of MG patients with ptosis. Although the ptosis 
crutch described herein was designed for the MG patient population, there is reason 
to believe that the use of the ptosis crutch could be extended to persons with ptosis 
from other aetiologies.  
This multidisciplinary project used a bio-psychosocial approach, in that it 
acknowledged the anatomy and biomechanics of the eye as well as the social and 
psychological considerations of the MG patients. 
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 6.1 Limitations 
1. The study did not quantify the effect of the ptosis crutch on the patient’s visual 
field. The effectivity (if any) of the ptosis crutch on the improving the visual field 
was determined by the subjective rating of the user. Further investigations 
should consider quantifying improvement (if any) of the user’s visual function. 
2. The diameter of the pupil is subject to change according to varying lighting 
conditions. Although the device is adjustable, the amount of elevation was 
determined according to a 3mm pupil (ambient lighting conditions). 
3. The same spectacle frame was used to test the ptosis crutch for all of the 
participants. The frame was not customized to fit the facial features of each 
participant.  
4. The use of 3D printing as the manufacturing method had several limitations. 
The choice of material and surface finishes of the material was limited. The 3D 
printer had a lower precision measurement when compared to other 
technologies, which limited the size of the ptosis crutch. The strength of the 
ptosis crutch is limited to the strength of the printable material.  
6.2 Future Work 
The clinical verification of the ptosis crutch was successful in that device satisfied the 
design requirements. That being said, there is future work that would be beneficial to 
the success of the device. The areas for future work, as suggested by the primary 
researcher, are listed below:   
1. Initial MG patient feedback has shown promising results for the ptosis crutch. 
Keeping this in mind it is ultimately the long-term feedback from all of the users 
that will confirm the success of the device design. 
2. The possibility of manufacturing the ptosis crutch using durable materials should 
be explored. The costs versus the benefits of a new manufacturing method 
should be investigated, once the long-term feedback from all the users has 
been determined. 
3.The application of the ptosis crutch to persons with ptosis with aetiologies other 
than MG should be explored.  
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It appears as though the ptosis crutch, described by this project, has the potential to 
offer a much-needed biomechanical solution to an African clinical problem. It is 
suggested that the recommended future work is explored, to facilitate the use of the 
ptosis crutch on a long-term basis.  
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Appendix One 
 
A1.1(a) Patient Information and consent document 
Study title: Design and development of a “ptosis crutch”  
Researcher and designer: Ms Megan Findlay 
Project supervisors: Dr Sudesh Sivarasu and Prof Jeannine Heckmann 
Summary of the research 
Thank you for considering being a participant on my study. The overall aim of this 
study is to develop a ptosis crutch that may provide a simple and effective solution to 
alleviating the drooping upper eyelid symptoms of ptosis. The basic aim of the study 
is to design, construct and test a ptosis crutch that is effective, user friendly and 
cosmetically acceptable.  
You are reading this document because you have a problem with drooping eyelids or 
ptosis. In plain language, this project aims to develop a device called a ptosis crutch, 
which will lift the drooping lids by a few millimetres so that it is easier to see out of the 
eye. This will allow you to see better whilst the medicines take effect on the eyelids - 
which can take several months to years. In some patients, the current medicines do 
not help the eyelids or ptosis even if it does help the other muscles- the ptosis crutch 
may then become a long-term device to help you read and live an active fulfilling life.  
In order to find an effective solution to this problem we will ask individuals like yourself 
who present with ptosis symptoms (either on one or both sides), whether you wish to 
participate in this research. The research will require that you participate in three 
separate assessments. All assessments will include filling out a questionnaire as well 
the investigator taking three portrait photographs of you (eyes in up gaze, down gaze 
and primary gaze/looking straight ahead). The photographs will be used for the 
research purpose of taking eye measurement only and will not be stored on any public 
data bases. Following the termination of the current project the photographs will be 
safely discarded should the patient not give consent to using the photograph in the 
write-up of the study. 
The questionnaire relates to how much difficulty you experience with your vision 
during your everyday life and how much it impacts on your life experience. We will 
then follow with a questionnaire after you have been fitted with a ptosis crutch to 
assess how much benefit or not, there has been
 
 
You may decide not to take part in this study. It is entirely voluntary to take part. If 
you decide against taking part, you will still be part of the MG clinic and receive care 
like all the other patients. You can also decide to leave the study at any time without 
telling us the reason and it will not affect your care. If you are less than 18 years of 
age you and a parent will need to sign your consent to take part.  
Once the design and development of the crutches are complete we will make a few 
pairs for participants to try. We are hoping that all the patients (whether you took part 
in the study or not) will eventually have access to the ptosis crutches. 
The risks associated with the crutch are expected to be similar to the risk of wearing 
reading glasses. You have to place it carefully on the face. Although this is a low risk 
study the University of Cape Town (UCT) does have no-fault insurance in case, 
unexpectedly something goes wrong with the ptosis crutch.  
What if Something Goes Wrong? 
UCT has insurance cover for the event that research-related injury or harm results 
from your participation in the trial. The insurer will pay all reasonable medical 
expenses in accordance with the South African Good Clinical Practice Guidelines 
(DoH 2006), based on the Association of the British Pharmaceutical Industry 
Guidelines (ABPI) in the event of an injury or side effect resulting directly from your 
participation in the trial. You will not be required to prove fault on the part of the 
University. 
The University will not be liable for any loss, injuries and/or harm that you may 
sustain where the loss is caused by: 
 The use of unauthorised medicine or substances during the study 
 Any injury that results from you not following the protocol requirements or the 
instructions that the study doctor may give you 
 Any injury that arises from inadequate action or lack of action to deal 
adequately with a side effect or reaction to the study medication 
 An injury that results from negligence on your part 
[Researchers must bear in mind that it is unacceptable to impose a burden on 
participants who may not recognize symptoms or have the ready means to take 
action.] 
 
 
“By agreeing to participate in this study, you do not give up your right to claim 
compensation for injury where you can prove negligence, in separate litigation. In 
particular, your right to pursue such a claim in a South African court in terms of South 
African law must be ensured. Note, however, that you will usually be requested to 
accept that payment made by the University under the SA GCP guideline 4.11 is in 
full settlement of the claim relating to the medical expenses. “ 
An injury is considered trial-related if, and to the extent that, it is caused by study 
activities. You must notify the study doctor immediately of any side effects and/or 
injuries during the trial, whether they are research-related or other related 
complications. 
UCT reserves the right not to provide compensation if, and to the extent that, your 
injury came about because you chose not to follow the instructions that you were 
given while you were taking part in the study. Your right in law to claim compensation 
for injury where you prove negligence is not affected. Copies of these guidelines are 
available on request. 
If you have questions about your rights as study participant, and in the event 
of trial-related injury, please contact: The head of the UCT Faculty of Health 
Sciences Research Ethics Committee, Prof Marc Blockman, Tel: 021 406 6496 
If you have questions about the study, please contact:
Megan Findlay 
Tel: 0764124608   
Email: fndmeg001@myuct.ac.za 
Prof Jeannine Heckmann  
Tel: 021-404-3263 
Email:jeanine.heckmann@uct.ac.za
 
 
Participant consent 
I        do hereby voluntarily consent to participate 
in this study. I realize that my anonymity will be protected at all times, and agree to 
allowing the information gathered in the study to be used and published for scientific 
purposes. I have read and understand the information above and all questions have 
been answered to my satisfaction. I am willing to have photographs taken of me for 
the research purpose of obtaining my eye measurement. I am willing to have the 
photographs taken of me used in the final publication of this study, under the condition 
that only the identifiable features that will be visible will be my eyes. Should I not be 
willing for my photograph to be published I will indicate in the space provided below. 
(Please tick the appropriate box) 
 
 
 
             
Signature of participant        Date  
(Legal guardian should the participant be younger than 18) 
 
    
Name of person taking consent 
 
                                           
Signature of person taking consent        Date 
YES 
NO 
 
 
A1.1(b) Assent form for participants younger than 18 years 
I am Megan, a student at the University of Cape Town. My project is to design and develop a 
‘ptosis crutch’ and I am asking you to take part in this study – but only if you want to. You may 
say yes or no – it is up to you. There is no right or wrong choice- as long as you understand what 
it involves and it is your choice. The main aim is to develop a device called a ‘ptosis crutch’ that 
will help lift up your drooping eyelid(s) so that it is easier for you to see. The figure shows an old 
design attached to a pair of reading glasses. I will try and develop a few different styles and 
types and will then ask your opinion as to which one you prefer wearing, and why you prefer it. 
The idea is to design it so that you will use it and that it will help you in your everyday life. 
What will I have to do? 
If you take part in this study we will need to ask you questions on three different occasions and 
you have will need to fill in a form. We will also need to take 3 photographs of you face (of your 
eyes and nose). The photographs will be used for taking the eye measurements that are needed 
for designing the ‘ptosis crutch’.  
The question forms will be used to gather information about the difficulties that you may 
experience due to your drooping eyelids. After the crutch has been designed and you have used 
it we will ask you more questions to find out if the crutch has helped you.  You can choose to 
leave out any questions that you feel are not necessary to your situation or if they make you feel 
uncomfortable. 
Will participating in this study hurt or help me in any way? 
Participating in this study should not hurt you. The ptosis crutch, like any pair of reading glasses, 
must be looked after and used with care when playing games.  
Figure: A pair of glasses with the 'ptosis crutch' attached. 
 
 
By participating in this study you will contribute towards developing a device that will hopefully 
be beneficial to you and other patients in the future. We are hoping to give each of our patients 
with longstanding ptosis one of these crutches even if you have not been part of the study. 
However, if you take part we will use your suggestions and requests in the design process.  
If you have any questions about your rights as study participant, and in the event of you 
getting hurt in the trial, you must please contact: 
Prof Marc Blockman (The head of the UCT Research Ethics Committee) 
Tel: 021 406 6496 
What will you do with information about me? 
We will be very careful to keep your answers to the questions as well as the photographs taken 
published in a magazine (known as scientific paper) which is only read by doctors and scientists. 
However, no-one will be able to recognize you. If you are happy for us to use the photos of your 
eyes for a scientific paper then please say yes. If you would rather not, you can say no. It will 
look something like this picture: 
 
Yes, you can use my photo in the journal                 or no thanks  
If you have questions about the study please contact: 
Megan Findlay 
Number: 0764124608 
Email: fndmeg001@myuct.ac.za 
Prof Jeannine Heckmann 
Number: 021 404 3263 
Email:jeanine.heckmann@uct.ac.za
  
Agreement 
If you decide you want to be in this study, please print/write your name.   
I, ____________________________ (print your name) would like to take part in this ptosis 
crutch design study. 
_____________________________               ________________ 
            (Signature)  (Date of assent
 
 
A1.2 The adapted NEI-VFQ-25 
The following is a survey with statements about problems which involve your vision or 
feelings that you have about your vision condition. After each question please choose the 
response that best describes your situation. Please answer all the questions as if you 
were wearing your glasses or contact lenses (if any). Please take as much time as you 
need to answer each question. All your answers are confidential and will be seen only by 
Prof Heckmann or Ms Findlay. However, Prof Heckmann will correlate your examination 
findings with your responses to these questions so that we can understand your disability 
better. In order for this survey to improve our knowledge about vision problems and how 
they affect your quality of life, your answers must be as accurate as possible. 
INSTRUCTIONS 
1. In general we would like to have people try to complete these forms on their own. If 
you find that you need assistance, please feel free to ask the researcher to assist you. 
2. Please answer every question. 
3. Answer the questions by circling the appropriate number. 
4. If you are unsure of how to answer a question, please give the best answer you can 
and make a comment in the left margin. 
STATEMENT OF CONFIDENTIALITY 
All information that would permit identification of any person who completed this 
questionnaire will be regarded as strictly confidential. Such information will be used only 
for the purposes of this study and will not be disclosed or released for any other purposes 
without prior consent, except as required by law. 
Name: ______________________  Age: __________ 
 
Date: _______________________  MG composite eye score: _______ 
 
 
 
 
GENERAL VISION 
Please rate the following questions as Excellent, Good, Fair, Poor or Very poor, 
according to your personal situation. 
 
1. Is your current vision using both eyes (with glasses or contact lenses, if you wear 
them) ……….? 
 
 
 
 
 
2. Is your current upper visual field ……….? 
 
 
 
 
 
3. Is your current general level of health ……….? 
 
 
 
 
 
4. Is your current eye/eyelid appearance ……….? 
 
 
1 2 3 4 5 
Excellent Good Fair Poor Very poor 
1 2 3 4 5 
Excellent Good Fair Poor Very poor 
1 2 3 4 5 
Excellent Good Fair Poor Very poor 
1 2 3 4 5 
Excellent Good Fair Poor Very poor 
 
 
DIFFICULTY WITH ACTIVITIES 
The next questions are about how much difficulty, if any, you have doing certain 
activities with ptosis. 
5.  How much difficulty do you have when reading due to the position of your 
eyelid(s)? 
6.  
 
 
 
 
7. How much difficulty do you have when watching TV due to the position of your 
eyelid(s)? 
 
 
 
 
 
8. How much difficulty do you have using a computer due to the position of your 
eyelid(s)? 
 
 
 
 
 
 
9. How much difficulty do going down steps, stairs or around curbs due to the 
position of your eyelid(s)? 
 
1 2 3 4 5 
No difficulty A little difficulty Moderately 
difficult 
Extremely 
difficult 
Cannot due this 
due to my 
drooping eyelids 
1 2 3 4 5 
No difficulty A little difficulty Moderately 
difficult 
Extremely 
difficult 
Cannot due 
this due to my 
drooping 
eyelids 
1 2 3 4 5 
No difficulty Occasional 
difficulty 
Mild difficulty Moderate 
difficulty 
Severe 
difficulty 
1 2 3 4 5 
No difficulty Occasional 
difficulty 
Mild difficulty Moderate 
difficulty 
Severe 
difficulty 
 
 
10. How much difficulty do you have identifying objects due to the position of your 
eyelid(s)? 
 
 
 
 
 
11. How much difficulty do you hanging or reaching objects (plants, light bulbs, 
dishes) due to the position of your eyelid(s)? 
 
 
 
 
 
12. Do you get less done (accomplish less) than you would like because of your 
ptosis?  
In other words, do you think your ptosis/lid drooping prevents you from doing 
everything you would like to do? 
  
 
 
 
 
13. How much difficulty do you have performing your occupation as a (fill in) 
………………… due to the position of your eyelid(s)? 
 
 
1 2 3 4 5 
No difficulty A little difficulty Moderately 
difficult 
Extremely 
difficult 
Cannot due 
this due to my 
drooping 
eyelids 
1 2 3 4 5 
No difficulty Occasional 
difficulty 
Mild difficulty Moderate 
difficulty 
Severe 
difficulty 
1 2 3 4 5 
No difficulty Occasional 
difficulty 
Mild difficulty Moderate 
difficulty 
Severe 
difficulty 
1 2 3 4 5 
All of the time Most of the 
time 
Some of the 
time 
A little of the 
time 
Never 
 
 
14. Because of your eyesight, how much difficulty do you have doing things like 
shaving, styling your hair, or putting on makeup? 
 
 
 
 
 
15. How much of the time do you worry about your drooping eyelids? 
1 2 3 4 5 
None of the 
time 
A little of the 
time 
Some of the 
time 
Most of the 
time 
All of the time 
1 2 3 4 5 
No difficulty at 
all 
A little difficulty Moderate 
difficulty 
Extreme 
difficulty 
Cannot do this 
due to my 
drooping eyelids 
 
 
A1.3 Ptosis crutch usability questionnaire 
 
NAME:          DATE: 
Please answer the following questions relating to the ptosis crutch you are currently 
wearing by circling the appropriate option. If you find that you need assistance, please 
feel free to ask the researcher to assist you. 
 
1. How comfortable is the crutch from unbearable to unnoticeable? 
 
 
 
 
 
2. How does wearing the crutch compare to not wearing the crutch? 
 
 
 
 
3. Have you experienced any skin irritations/allergies caused by the crutch? 
 
 
 
 
4. Does the crutch impose on your visual field? 
 
1 2 3 4 5 
Extremely 
uncomfortable 
Uncomfortable Bearable Comfortable Extremely 
comfortable 
1 2 3 4 5 
Much worse Worse No change Somewhat 
better 
Much better 
Yes No 
1 2 3 4 
Completely 
distracting 
Somewhat 
distracting 
Somewhat 
noticeable 
 
Not at all 
noticeable 
 
 
 
5. Has the crutch effected your ability to blink normally? 
 
 
 
 
 
 
6. How easy or difficult was it to attach and remove the crutch from your glasses? 
 
 
 
 
 
 
 
7. How well does the crutch fit you? (Please circle the tight or loose option if 
necessary) 
 
 
 
 
8. How do you think the crutch effects your appearance? 
 
 
 
 
 
1 2 3 4 
Cannot blink Very difficult to 
blink 
Somewhat 
difficult to blink 
Blink normally 
 
1 2 3 4 5 
I cannot 
remove the 
crutch 
Very difficult Difficult Somewhat 
easy 
Very easy 
1 2 3 4 5 
Terribly 
Tight/ loose 
Not well 
Tight/ loose 
 
Bearable Quite well Very well 
1 2 3 4 5 
Much worse Worse No change A slight 
improvement 
Much of an 
improvement 
 
 
9. Would you be interested in using a crutch such as this permanently? 
 
 
 
10. Please provide any additional information that you would like the researchers to 
know about this ptosis crutch design. 
             
             
             
             
             
Yes No 
Appendix Two 
 
A2.1 The ptosis crutch design specification form 
 
What will it look like? The appearance of the ptosis crutch cannot be likened to that of any 
existing device 
What materials is the device 
made from? 
The device is manufactured from different materials, depending on 
the function of the specific component: 
1. Attachment: ABS                                                                                
2. Housing for crutch bar: ABS                                                                
3. Curved crutch bar: galvanized wire coated with polyvinyl tubing                                                                                   
4. Control: ABS 
What is the size of the device? 
Attachment: length= 18mm; height = variable                                                                  
Control: width= 12.5mm; height= 15.75mm                                                                                      
Crutch bar:  width= 33.92mm; height= 30.25mm 
 
             FUNCTION 
What does the device do? 
The product will provide the user with the ability to elevate their 
eyelid to clear the visual axis 
How does it achieve its 
intended outcome? 
The product is attached to the superior border of the user’s 
spectacle frame. The device is adjusted to fit the horizontal position 
of the eye as well as the globe projection. The curved crutch bar 
should fit comfortably on the upper eyelid, above the eyelid margin. 
Once in place the crutch is able to adjust the eyelid position along 
the z axis using the lever. 
What are the special features 
The device is modular in that it is composed of three independent 
components. The device is adjustable along the x, y, and z axes by 
the user. 
                      USER 
What is the device used for? 
The device is used by Myasthenia Gravis patients with ptosis. The 
device is intended to elevate the upper eyelid of the user. 
What does the user want to do 
with the device? 
The user will attach to device to the superior border of their 
spectacle frame. They will fit the crutch to their eyelid when their 
spectacles are in position. The user hopes to use the device to 
elevate their eyelid to clear this visual axis. 
Where will the device be used 
The device will be used in in day to day activities. The device is 
intended to be worn by the user when required 
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